<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="/ProjectMundo/style/jats-html.xsl"?>
<!DOCTYPE response>
<article article-type="research-article" dtd-version="1.2" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    41467
   </journal-id>
   <journal-id journal-id-type="doi">
    10.1038/41467.2041-1723
   </journal-id>
   <journal-title-group>
    <journal-title>
     Nature Communications
    </journal-title>
    <abbrev-journal-title abbrev-type="publisher">
     Nat Commun
    </abbrev-journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2041-1723
   </issn>
   <publisher>
    <publisher-name>
     Nature Publishing Group UK
    </publisher-name>
    <publisher-loc>
     London
    </publisher-loc>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">
    s41467-024-46116-y
   </article-id>
   <article-id pub-id-type="manuscript">
    46116
   </article-id>
   <article-id pub-id-type="doi">
    10.1038/s41467-024-46116-y
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Article
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/499
     </subject>
    </subj-group>
    <subj-group subj-group-type="SubjectPath">
     <subject>
      /692/308/575
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /141
     </subject>
    </subj-group>
    <subj-group subj-group-type="TechniquePath">
     <subject>
      /38/23
     </subject>
    </subj-group>
    <subj-group subj-group-type="NatureArticleTypeID">
     <subject>
      article
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">
     肠道微生物群调节对肌肉功能和认知的影响：PROMOTe随机对照试验
    </article-title>
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" corresp="yes" id="Au1">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5702-1759
     </contrib-id>
     <name name-style="western">
      <surname>
       Ni Lochlainn
      </surname>
      <given-names>
       Mary
      </given-names>
     </name>
     <address>
      <email>
       mary.ni_lochlainn@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor1">
      a
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au2">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6941-8160
     </contrib-id>
     <name name-style="western">
      <surname>
       Bowyer
      </surname>
      <given-names>
       Ruth C. E.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="aff" rid="Aff2">
      2
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au3">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-3514-4528
     </contrib-id>
     <name name-style="western">
      <surname>
       Moll
      </surname>
      <given-names>
       Janne Marie
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff3">
      3
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au4">
     <name name-style="western">
      <surname>
       García
      </surname>
      <given-names>
       María Paz
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au5">
     <name name-style="western">
      <surname>
       Wadge
      </surname>
      <given-names>
       Samuel
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au6">
     <name name-style="western">
      <surname>
       Baleanu
      </surname>
      <given-names>
       Andrei-Florin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au7">
     <name name-style="western">
      <surname>
       Nessa
      </surname>
      <given-names>
       Ayrun
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au8">
     <name name-style="western">
      <surname>
       Sheedy
      </surname>
      <given-names>
       Alyce
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au9">
     <name name-style="western">
      <surname>
       Akdag
      </surname>
      <given-names>
       Gulsah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au10">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-9066-4614
     </contrib-id>
     <name name-style="western">
      <surname>
       Hart
      </surname>
      <given-names>
       Deborah
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au11">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0003-0925-4632
     </contrib-id>
     <name name-style="western">
      <surname>
       Raffaele
      </surname>
      <given-names>
       Giulia
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff4">
      4
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au12">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-7904-7933
     </contrib-id>
     <name name-style="western">
      <surname>
       Seed
      </surname>
      <given-names>
       Paul T.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff5">
      5
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au13">
     <name name-style="western">
      <surname>
       Murphy
      </surname>
      <given-names>
       Caroline
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff6">
      6
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au14">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-8203-0769
     </contrib-id>
     <name name-style="western">
      <surname>
       Harridge
      </surname>
      <given-names>
       Stephen D. R.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff7">
      7
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au15">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-6702-3704
     </contrib-id>
     <name name-style="western">
      <surname>
       Welch
      </surname>
      <given-names>
       Ailsa A.
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff8">
      8
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au16">
     <name name-style="western">
      <surname>
       Greig
      </surname>
      <given-names>
       Carolyn
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff9">
      9
     </xref>
     <xref ref-type="aff" rid="Aff10">
      10
     </xref>
     <xref ref-type="aff" rid="Aff11">
      11
     </xref>
    </contrib>
    <contrib contrib-type="author" id="Au17">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0001-5414-2950
     </contrib-id>
     <name name-style="western">
      <surname>
       Whelan
      </surname>
      <given-names>
       Kevin
      </given-names>
     </name>
     <xref ref-type="aff" rid="Aff12">
      12
     </xref>
    </contrib>
    <contrib contrib-type="author" corresp="yes" id="Au18">
     <contrib-id contrib-id-type="orcid">
      http://orcid.org/0000-0002-4910-0489
     </contrib-id>
     <name name-style="western">
      <surname>
       Steves
      </surname>
      <given-names>
       Claire J.
      </given-names>
     </name>
     <address>
      <email>
       claire.j.steves@kcl.ac.uk
      </email>
     </address>
     <xref ref-type="aff" rid="Aff1">
      1
     </xref>
     <xref ref-type="corresp" rid="IDs4146702446116y_cor18">
      u
     </xref>
    </contrib>
    <aff id="Aff1">
     <label>
      1
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London
      </institution>
      <institution content-type="org-name">
       Department of Twin Research and Genetic Epidemiology
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 7EH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff2">
     <label>
      2
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/035dkdb55
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.499548.d
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 5903 3632
      </institution-id>
      <institution content-type="org-name">
       The Alan Turing Institute
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NW1 2DB
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff3">
     <label>
      3
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/00g934978
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.509919.d
      </institution-id>
      <institution content-type="org-name">
       Clinical Microbiomics
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Copenhagen
     </addr-line>
     <country country="DK">
      Denmark
     </country>
    </aff>
    <aff id="Aff4">
     <label>
      4
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       GKT School of Medical Education
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff5">
     <label>
      5
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Unit for Medical Statistics/Department for Women and Children’s Health, School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff6">
     <label>
      6
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s Clinical Trials Unit, Research Management and Innovation Directorate
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff7">
     <label>
      7
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       Centre for Human &amp; Applied Physiological Sciences
      </institution>
      <institution content-type="org-name">
       King’s College London
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff8">
     <label>
      8
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/026k5mg93
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.8273.e
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 1092 7967
      </institution-id>
      <institution content-type="org-division">
       Department of Epidemiology and Public Health, Norwich Medical School
      </institution>
      <institution content-type="org-name">
       University of East Anglia
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      NR4 7TJ
     </addr-line>
     <addr-line content-type="city">
      Norwich
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff9">
     <label>
      9
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/03angcq70
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.6572.6
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 1936 7486
      </institution-id>
      <institution content-type="org-division">
       School of Sport, Exercise, and Rehabilitation Sciences
      </institution>
      <institution content-type="org-name">
       University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff10">
     <label>
      10
     </label>
     <institution-wrap>
      <institution content-type="org-name">
       MRC-Versus Arthritis Centre for Musculoskeletal Ageing Research
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff11">
     <label>
      11
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/014ja3n03
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.412563.7
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0004 0376 6589
      </institution-id>
      <institution content-type="org-division">
       NIHR Birmingham Biomedical Research Centre
      </institution>
      <institution content-type="org-name">
       University Hospitals Birmingham NHS Foundation Trust and University of Birmingham
      </institution>
     </institution-wrap>
     <addr-line content-type="city">
      Birmingham
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
    <aff id="Aff12">
     <label>
      12
     </label>
     <institution-wrap>
      <institution-id institution-id-type="ROR">
       https://ror.org/0220mzb33
      </institution-id>
      <institution-id institution-id-type="GRID">
       grid.13097.3c
      </institution-id>
      <institution-id institution-id-type="ISNI">
       0000 0001 2322 6764
      </institution-id>
      <institution content-type="org-division">
       King’s College London, Department of Nutritional Sciences
      </institution>
      <institution content-type="org-name">
       Franklin Wilkins Building
      </institution>
     </institution-wrap>
     <addr-line content-type="postcode">
      SE1 9NH
     </addr-line>
     <addr-line content-type="city">
      London
     </addr-line>
     <country country="GB">
      UK
     </country>
    </aff>
   </contrib-group>
   <author-notes>
    <corresp id="IDs4146702446116y_cor1">
     <label>
      a
     </label>
     <email>
      mary.ni_lochlainn@kcl.ac.uk
     </email>
    </corresp>
    <corresp id="IDs4146702446116y_cor18">
     <label>
      u
     </label>
     <email>
      claire.j.steves@kcl.ac.uk
     </email>
    </corresp>
   </author-notes>
   <pub-date date-type="pub" publication-format="electronic">
    <day>
     29
    </day>
    <month>
     2
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <pub-date date-type="collection" publication-format="electronic">
    <month>
     12
    </month>
    <year>
     2024
    </year>
   </pub-date>
   <volume>
    15
   </volume>
   <issue seq="1859">
    1
   </issue>
   <elocation-id>
    1859
   </elocation-id>
   <history>
    <date date-type="registration">
     <day>
      15
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="received">
     <day>
      4
     </day>
     <month>
      8
     </month>
     <year>
      2023
     </year>
    </date>
    <date date-type="accepted">
     <day>
      12
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="online">
     <day>
      29
     </day>
     <month>
      2
     </month>
     <year>
      2024
     </year>
    </date>
   </history>
   <pub-history>
    <event event-type="Correction">
     <event-desc>
      A Correction to this paper has been published: https://doi.org/10.1038/s41467-025-58771-w
     </event-desc>
     <date>
      <day>
       10
      </day>
      <month>
       4
      </month>
      <year>
       2025
      </year>
     </date>
    </event>
   </pub-history>
   <permissions>
    <copyright-statement content-type="compact">
     © The Author(s) 2024
    </copyright-statement>
    <copyright-statement content-type="comment">
     corrected publication 2025
    </copyright-statement>
    <copyright-year>
     2024
    </copyright-year>
    <copyright-holder>
     The Author(s)
    </copyright-holder>
    <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
     <license-p>
      <bold>
       Open Access
      </bold>
      This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit
      <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">
       http://creativecommons.org/licenses/by/4.0/
      </ext-link>
      .
     </license-p>
    </license>
   </permissions>
   <related-article ext-link-type="doi" related-article-type="correction-forward" xlink:href="10.1038/s41467-025-58771-w"/>
   <abstract id="Abs1" xml:lang="en">
    <title>
     摘要
    </title>
    <p id="Par1">
     研究表明，诱导肠道微生物群变化可能改变肌肉生理和认知行为。肠道微生物群可能在老年肌肉的代谢抵抗和认知中发挥作用。在这项安慰剂对照的双盲随机对照试验中，36对双胞胎（72名个体），年龄≥60岁，每对双胞胎被随机分配到接受安慰剂或益生元的组中，连续12周。所有参与者被要求进行阻力训练和支配链氨基酸（BCAA）补充。结果包括身体功能和认知。试验通过视频访问、在线问卷和认知测试以及设备和生物样本的邮寄进行。益生元补充剂被证明是安全的，并导致肠道微生物群的变化[例如，相对双歧杆菌丰度增加]。在椅子站立时间的主要结果中，益生元和安慰剂之间没有显著差异（β = 0.579；95% CI −1.080-2.239 p = 0.494）。益生元改善了认知（因子评分与安慰剂相比（β = −0.482；95% CI，−0.813，−0.141；p = 0.014））。我们的结果表明，廉价且易得的肠道微生物群干预可能改善我们老龄化人口的认知。我们证明了远程交付试验对老年人的可行性，这可能会减少老年人在临床试验中的代表性不足。ClinicalTrials.gov注册号：NCT04309292。
    </p>
   </abstract>
   <abstract abstract-type="ShortSummary" id="Abs2" xml:lang="en">
    <p id="Par2">
     Here, the authors present the results of the PROMOTe trial, reporting improved cognition with prebiotic vs placebo in twins over 60 years old, probing that remote trials are feasible in older adults, and suggesting that the gut microbiota may represent a therapeutic target for age-associated morbidity.
    </p>
   </abstract>
   <kwd-group kwd-group-type="publisher-auto-generated" vocab="springer-nature-taxonomy" xml:lang="en">
    <kwd>
     Microbiome
    </kwd>
    <kwd>
     Nutritional Supplements
    </kwd>
    <kwd>
     Microbiota
    </kwd>
    <kwd>
     Cognitive ageing
    </kwd>
    <kwd>
     Placebo Effect
    </kwd>
    <kwd>
     Preclinical Research
    </kwd>
   </kwd-group>
   <kwd-group kwd-group-type="hierarchical" vocab="FoR" vocab-identifier="ANZSRC 2008">
    <kwd content-type="term" vocab-term-identifier="11">
     Medical and Health Sciences
    </kwd>
    <nested-kwd>
     <kwd content-type="term" vocab-term-identifier="1103">
      Clinical Sciences
     </kwd>
    </nested-kwd>
   </kwd-group>
   <funding-group>
    <award-group>
     <funding-source>
      <institution-wrap>
       <institution>
        DH | National Institute for Health Research (NIHR)
       </institution>
       <institution-id institution-id-type="doi" vocab="open-funder-registry">
        https://doi.org/10.13039/501100000272
       </institution-id>
      </institution-wrap>
     </funding-source>
     <award-id award-type="FundRef grant">
      NIHR300159
     </award-id>
     <principal-award-recipient>
      <name name-style="western">
       <surname>
        Ni Lochlainn
       </surname>
       <given-names>
        Mary
       </given-names>
      </name>
     </principal-award-recipient>
    </award-group>
   </funding-group>
   <custom-meta-group>
    <custom-meta>
     <meta-name>
      publisher-imprint-name
     </meta-name>
     <meta-value>
      Nature Portfolio
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-issue-count
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-article-count
     </meta-name>
     <meta-value>
      10926
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-pricelist-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-holder
     </meta-name>
     <meta-value>
      Springer Nature Limited
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-copyright-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-contains-esm
     </meta-name>
     <meta-value>
      Yes
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-year
     </meta-name>
     <meta-value>
      2024
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-month
     </meta-name>
     <meta-value>
      2
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-registration-date-day
     </meta-name>
     <meta-value>
      15
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      toc-levels
     </meta-name>
     <meta-value>
      0
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      volume-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-product
     </meta-name>
     <meta-value>
      NonStandardArchiveJournal
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      numbering-style
     </meta-name>
     <meta-value>
      Unnumbered
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-grants-type
     </meta-name>
     <meta-value>
      OpenChoice
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      metadata-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      abstract-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodypdf-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bodyhtml-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      bibliography-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      esm-grant
     </meta-name>
     <meta-value>
      OpenAccess
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      online-first
     </meta-name>
     <meta-value>
      false
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-file-reference
     </meta-name>
     <meta-value>
      BodyRef/PDF/41467_2024_Article_46116.pdf
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      pdf-type
     </meta-name>
     <meta-value>
      Typeset
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      target-type
     </meta-name>
     <meta-value>
      OnlinePDF
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-year
     </meta-name>
     <meta-value>
      2025
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-month
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-online-date-day
     </meta-name>
     <meta-value>
      1
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      issue-type
     </meta-name>
     <meta-value>
      Regular
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      article-type
     </meta-name>
     <meta-value>
      OriginalPaper
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-primary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, Humanities and Social Sciences, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-secondary
     </meta-name>
     <meta-value>
      Science, multidisciplinary
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      journal-subject-collection
     </meta-name>
     <meta-value>
      Science (multidisciplinary)
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      open-access
     </meta-name>
     <meta-value>
      true
     </meta-value>
    </custom-meta>
    <custom-meta>
     <meta-name>
      discipline
     </meta-name>
     <meta-value>
      Humanities and Social Sciences
     </meta-value>
    </custom-meta>
   </custom-meta-group>
  </article-meta>
  <notes notes-type="CrossLinking">
   <sec>
    <p>
     A correction to this article is available online at
     <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-025-58771-w">
      https://doi.org/10.1038/s41467-025-58771-w
     </ext-link>
     .
    </p>
   </sec>
  </notes>
 </front>
 <body>
  <sec id="Sec1" sec-type="introduction">
   <title>
    介绍
   </title>
   <p id="Par3">
    全球人口的平均年龄正在上升。因此，年龄相关疾病和与年龄相关的发病率的时间，包括肌肉流失和认知功能下降，都在增加。痴呆症的发病率在全球范围内正在增长，但随着人口老龄化，认识到可以作为健康老龄化的一部分发生的认知变化，对于与老年人合作的研究人员和临床医生来说将变得越来越重要。运动可以减缓肌肉流失和认知功能下降
    <sup>
     <xref ref-type="bibr" rid="CR1">
      1
     </xref>
     <xref ref-type="bibr" rid="CR2">
      2
     </xref>
     <xref ref-type="bibr" rid="CR3">
      3
     </xref>
     <xref ref-type="bibr" rid="CR4">
      4
     </xref>
     <xref ref-type="bibr" rid="CR5">
      5
     </xref>
    </sup>
    。有很多原因可以解释为什么老年人可能难以遵循运动计划，这些计划的已知效益是改善健康和功能，这对研究人员和临床医生来说是一个挑战。因此，需要能够证明提供广泛的身体和精神益处的干预措施。
   </p>
   <p id="Par4">
    人类在年龄增长的过程中会失去骨骼肌，这可能会发展成肌肉萎缩症。饮食蛋白质对于维持骨骼肌健康至关重要；然而，包括社会孤立、吞咽困难和胃排空速度变慢在内的几个因素可能会导致老年人蛋白质摄入量降低
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    。除了摄入较少的饮食蛋白质外，研究表明老年人对蛋白质摄入表现出代谢抵抗，即老年肌肉对蛋白质摄入的反应性降低，相比年轻成年人
    <sup>
     <xref ref-type="bibr" rid="CR7">
      7
     </xref>
    </sup>
    。这导致专家推荐每天摄入1-1.3克/千克/天的蛋白质，相比英国成年人参考营养摄入量的0.8克/千克/天
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    。
   </p>
   <p id="Par5">
    骨骼肌质量由肌肉蛋白质合成和分解（MPS和MPB）过程调节。MPS速率主要受食物摄入和身体活动等促进蛋白质合成的刺激的反应性控制。老年人往往具有更高的疾病、身体不活动和炎症等分解应激因素。代谢抵抗的病因复杂，涉及年龄生理和身体不活动。研究表明，蛋白质补充对肌肉功能的影响最显著的是与抗阻力运动结合使用
    <sup>
     <xref ref-type="bibr" rid="CR8">
      8
     </xref>
    </sup>
    。抗阻力运动是骨骼肌的强效促进蛋白质合成的刺激，蛋白质和运动结合使用时具有协同作用
    <sup>
     <xref ref-type="bibr" rid="CR9">
      9
     </xref>
     <xref ref-type="bibr" rid="CR10">
      10
     </xref>
     <xref ref-type="bibr" rid="CR11">
      11
     </xref>
    </sup>
    。
   </p>
   <p id="Par6">
    最近的研究表明，肠道微生物群可能对老年人的认知和身体功能都很重要。肠道微生物群由居住在肠道中的细菌、古菌、病毒和真核微生物组成，以及它们的基因组和周围环境
    <sup>
     <xref ref-type="bibr" rid="CR12">
      12
     </xref>
    </sup>
    。其在维持健康生理学方面的作用是一个迅速发展的研究领域。随着年龄的增长，肠道微生物群的恢复力降低，它变得更容易受到疾病、药物和生活方式变化的影响，表现为物种丰富度的变化和个体间变异性增加
    <sup>
     <xref ref-type="bibr" rid="CR13">
      13
     </xref>
     <xref ref-type="bibr" rid="CR14">
      14
     </xref>
     <xref ref-type="bibr" rid="CR15">
      15
     </xref>
     <xref ref-type="bibr" rid="CR16">
      16
     </xref>
    </sup>
    。肠道微生物群改变生理学的潜力已被动物粪便移植研究证明，这些研究表明受体的体成分变化反映了捐献者的phenotype
    <sup>
     <xref ref-type="bibr" rid="CR17">
      17
     </xref>
    </sup>
    。这突出了微生物群在表征代谢phenotype方面的作用。已经提出了几种代谢抵抗的机制，肠道微生物群被推测在其中许多机制中发挥作用
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
     <xref ref-type="bibr" rid="CR18">
      18
     </xref>
     <xref ref-type="bibr" rid="CR19">
      19
     </xref>
     <xref ref-type="bibr" rid="CR20">
      20
     </xref>
     <xref ref-type="bibr" rid="CR21">
      21
     </xref>
    </sup>
    。例如，蛋白质消化和吸收、肠道屏障功能和炎症
    <sup>
     <xref ref-type="bibr" rid="CR6">
      6
     </xref>
    </sup>
    。此外，有证据表明肠道微生物群可能通过分解途径影响骨骼肌
    <sup>
     <xref ref-type="bibr" rid="CR22">
      22
     </xref>
     <xref ref-type="bibr" rid="CR23">
      23
     </xref>
    </sup>
    。
   </p>
   <p id="Par7">
    益生元是被肠道微生物群选择性利用以改善健康的食物成分
    <sup>
     <xref ref-type="bibr" rid="CR24">
      24
     </xref>
    </sup>
    。益生元食物补充剂的管理已被证明可以改善老年人的弗里德尔脆弱性标准中的两个指标，即握力和疲劳以及整体脆弱性指数。另外，越来越多的证据支持肠脑轴，包括益生元补充对认知功能的有益影响的初步证据
    <sup>
     <xref ref-type="bibr" rid="CR25">
      25
     </xref>
     <xref ref-type="bibr" rid="CR26">
      26
     </xref>
     <xref ref-type="bibr" rid="CR27">
      27
     </xref>
    </sup>
    。因此，肠道微生物群可能代表一种可塑的治疗目标，用于预防和逆转与年龄相关的肌肉流失和认知功能下降。以前没有研究探讨过含有蛋白质和益生元的补充剂对老年人身体和认知功能的影响。基因和环境因素也会影响身体和认知功能，双胞胎内的随机化可以消除共享因素的方差，使研究更有力。据我们所知，其他研究尚未探讨过双胞胎人群中蛋白质和益生元补充剂的影响。
   </p>
   <p id="Par8">
    本研究旨在评估使用益生元调节肠道微生物群是否能改善肌肉功能（以5次椅子起立时间为衡量指标，作为肌肉力量的标志）与安慰剂相比，在所有参与者接受蛋白质（支链氨基酸[BCAA]）和抗阻力运动干预的试验中。该研究旨在测试肠道微生物群调节的添加是否能增强BCAA和运动相结合的既定肌肉功能改善。次要结果包括认知功能、握力、短期身体表现电池、食欲和肠道微生物群测量。使用双胞胎，他们在遗传和环境因素方面匹配得如此紧密，这加强了研究设计。
   </p>
  </sec>
  <sec id="Sec2" sec-type="results">
   <title>
    结果
   </title>
   <p id="Par9">
    共有626名个人被评估为合格者，其中72名被成功招募（36对双胞胎）。Fig
    <xref ref-type="fig" rid="Fig1">
     1
    </xref>
    显示了参与者通过试验的流程。招募于2021年5月开始。第一位参与者的第一次访问日期为2021年5月17日，最后一位参与者的第二次（最后一次）访问日期为2021年12月20日。表
    <xref ref-type="table" rid="Tab1">
     1
    </xref>
    包含了研究参与者的基线特征。参与者平均年龄为73岁（范围63-83岁），其中78%为女性（56/72）。在基线上，双臂匹配良好，如预期所示，考虑到双胞胎设计。然而，两个组在SNAQ食欲评分方面存在差异。因此，这被纳入随后的分析中作为潜在的混杂因素。食欲被纳入研究，因为我们知道肠道微生物群组成和蛋白质摄入受到食欲的影响
    <sup>
     <xref ref-type="bibr" rid="CR28">
      28
     </xref>
    </sup>
    。
    <fig id="Fig1" position="float">
     <label>
      Fig. 1
     </label>
     <caption xml:lang="zh-CN">
      <title>
       参与者流程图。
      </title>
      <p>
       试验中参与者的流程，包括评估资格、随机化、随访和分析。
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig1_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
    <table-wrap id="Tab1">
     <label>
      表 1
     </label>
     <caption xml:lang="zh-CN">
      <p>
       研究基线特征，按研究臂划分
      </p>
     </caption>
     <table frame="hsides" rules="groups">
      <thead>
       <tr>
        <th/>
        <th/>
        <th>
         <p>
          总计
         </p>
        </th>
        <th>
         <p>
          益生元组
         </p>
        </th>
        <th>
         <p>
          对照组
         </p>
        </th>
        <th>
         <p>
          <italic>
           p
          </italic>
          -值
         </p>
        </th>
       </tr>
       <tr>
        <th/>
        <th/>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 72
         </p>
        </th>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 36
         </p>
        </th>
        <th>
         <p>
          <italic>
           N
          </italic>
          = 36
         </p>
        </th>
        <th/>
       </tr>
      </thead>
      <tbody>
       <tr>
        <td>
         <p>
          年龄（岁）
         </p>
        </td>
        <td/>
        <td>
         <p>
          73.1 (4.8)
         </p>
        </td>
        <td>
         <p>
          73.1 (4.9)
         </p>
        </td>
        <td>
         <p>
          73.1 (4.9)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          性别
         </p>
        </td>
        <td>
         <p>
          女性
         </p>
        </td>
        <td>
         <p>
          56 (77.8%)
         </p>
        </td>
        <td>
         <p>
          28 (77.8%)
         </p>
        </td>
        <td>
         <p>
          28 (77.8%)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          男性
         </p>
        </td>
        <td>
         <p>
          16 (22.2%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          双生子类型
         </p>
        </td>
        <td>
         <p>
          同卵双生子
         </p>
        </td>
        <td>
         <p>
          44 (61.1%)
         </p>
        </td>
        <td>
         <p>
          22 (61.1%)
         </p>
        </td>
        <td>
         <p>
          22 (61.1%)
         </p>
        </td>
        <td>
         <p>
          1.000
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          异卵双生子
         </p>
        </td>
        <td>
         <p>
          28 (38.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          吸烟状态
         </p>
        </td>
        <td>
         <p>
          从未吸烟
         </p>
        </td>
        <td>
         <p>
          38 (52.8%)
         </p>
        </td>
        <td>
         <p>
          19 (52.8%)
         </p>
        </td>
        <td>
         <p>
          19 (52.8%)
         </p>
        </td>
        <td>
         <p>
          0.570
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          曾经吸烟
         </p>
        </td>
        <td>
         <p>
          30 (41.7%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          16 (44.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          当前吸烟
         </p>
        </td>
        <td>
         <p>
          4 (5.6%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td>
         <p>
          1 (2.8%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          家庭收入
         </p>
        </td>
        <td>
         <p>
          拒绝回答
         </p>
        </td>
        <td>
         <p>
          13 (18.1%)
         </p>
        </td>
        <td>
         <p>
          5 (13.9%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          0.590
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          低收入
         </p>
        </td>
        <td>
         <p>
          30 (41.7%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          16 (44.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          中等收入
         </p>
        </td>
        <td>
         <p>
          23 (31.9%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td>
         <p>
          9 (25.0%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          高收入
         </p>
        </td>
        <td>
         <p>
          6 (8.3%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td>
         <p>
          3 (8.3%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          教育水平
         </p>
        </td>
        <td>
         <p>
          低
         </p>
        </td>
        <td>
         <p>
          33 (45.8%)
         </p>
        </td>
        <td>
         <p>
          18 (50.0%)
         </p>
        </td>
        <td>
         <p>
          15 (41.7%)
         </p>
        </td>
        <td>
         <p>
          0.730
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          中等
         </p>
        </td>
        <td>
         <p>
          25 (34.7%)
         </p>
        </td>
        <td>
         <p>
          11 (30.6%)
         </p>
        </td>
        <td>
         <p>
          14 (38.9%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          高
         </p>
        </td>
        <td>
         <p>
          14 (19.4%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          酒精摄入
         </p>
        </td>
        <td>
         <p>
          从不饮酒
         </p>
        </td>
        <td>
         <p>
          20 (27.8%)
         </p>
        </td>
        <td>
         <p>
          12 (33.3%)
         </p>
        </td>
        <td>
         <p>
          8 (22.2%)
         </p>
        </td>
        <td>
         <p>
          0.510
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          每周饮酒不足
         </p>
        </td>
        <td>
         <p>
          17 (23.6%)
         </p>
        </td>
        <td>
         <p>
          7 (19.4%)
         </p>
        </td>
        <td>
         <p>
          10 (27.8%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          每周饮酒一次或以上
         </p>
        </td>
        <td>
         <p>
          35 (48.6%)
         </p>
        </td>
        <td>
         <p>
          17 (47.2%)
         </p>
        </td>
        <td>
         <p>
          18 (50.0%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          体重（kg）
         </p>
        </td>
        <td/>
        <td>
         <p>
          73.8 (15.7)
         </p>
        </td>
        <td>
         <p>
          71.8 (14.0)
         </p>
        </td>
        <td>
         <p>
          75.8 (17.2)
         </p>
        </td>
        <td>
         <p>
          0.280
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          身高（m）
         </p>
        </td>
        <td/>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          1.6 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.950
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          身体质量指数
         </p>
        </td>
        <td/>
        <td>
         <p>
          28.0 (5.1)
         </p>
        </td>
        <td>
         <p>
          27.3 (5.0)
         </p>
        </td>
        <td>
         <p>
          28.7 (5.3)
         </p>
        </td>
        <td>
         <p>
          0.240
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          蛋白质摄入量（g/d）
         </p>
        </td>
        <td/>
        <td>
         <p>
          60.7 (14.4)
         </p>
        </td>
        <td>
         <p>
          60.1 (16.2)
         </p>
        </td>
        <td>
         <p>
          61.3 (12.5)
         </p>
        </td>
        <td>
         <p>
          0.710
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          体重指数（g/kg/d）
         </p>
        </td>
        <td/>
        <td>
         <p>
          0.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.8 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.910
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          能量摄入量（kcals/d）
         </p>
        </td>
        <td/>
        <td>
         <p>
          1569.5 (397.7)
         </p>
        </td>
        <td>
         <p>
          1581.6 (380.5)
         </p>
        </td>
        <td>
         <p>
          1557.5 (419.2)
         </p>
        </td>
        <td>
         <p>
          0.800
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          脆弱性指数
         </p>
        </td>
        <td/>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.2 (0.1)
         </p>
        </td>
        <td>
         <p>
          0.790
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          步行速度（m/s）
         </p>
        </td>
        <td/>
        <td>
         <p>
          1.1 (0.4)
         </p>
        </td>
        <td>
         <p>
          1.1 (0.4)
         </p>
        </td>
        <td>
         <p>
          1.1 (0.3)
         </p>
        </td>
        <td>
         <p>
          0.640
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          椅子起立时间（s）
         </p>
        </td>
        <td/>
        <td>
         <p>
          10.6 (3.3)
         </p>
        </td>
        <td>
         <p>
          10.3 (3.2)
         </p>
        </td>
        <td>
         <p>
          11.0 (3.5)
         </p>
        </td>
        <td>
         <p>
          0.370
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          握力（kg）
         </p>
        </td>
        <td/>
        <td>
         <p>
          26.0 (9.7)
         </p>
        </td>
        <td>
         <p>
          25.7 (9.5)
         </p>
        </td>
        <td>
         <p>
          26.3 (10.0)
         </p>
        </td>
        <td>
         <p>
          0.800
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          平衡评分
         </p>
        </td>
        <td/>
        <td>
         <p>
          4.0 (0.2)
         </p>
        </td>
        <td>
         <p>
          4.0 (0.0)
         </p>
        </td>
        <td>
         <p>
          3.9 (0.2)
         </p>
        </td>
        <td>
         <p>
          0.160
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          短距离身体表现评分
         </p>
        </td>
        <td/>
        <td>
         <p>
          11.0 (1.5)
         </p>
        </td>
        <td>
         <p>
          10.9 (1.5)
         </p>
        </td>
        <td>
         <p>
          11.0 (1.5)
         </p>
        </td>
        <td>
         <p>
          0.810
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          IPAQ MET 分钟/周
         </p>
        </td>
        <td/>
        <td>
         <p>
          674.8 (654.5)
         </p>
        </td>
        <td>
         <p>
          564.8 (591.2)
         </p>
        </td>
        <td>
         <p>
          784.8 (703.2)
         </p>
        </td>
        <td>
         <p>
          0.160
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          IPAQ 评分
         </p>
        </td>
        <td>
         <p>
          低活动
         </p>
        </td>
        <td>
         <p>
          69 (95.8%)
         </p>
        </td>
        <td>
         <p>
          35 (97.2%)
         </p>
        </td>
        <td>
         <p>
          34 (94.4%)
         </p>
        </td>
        <td>
         <p>
          0.560
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          中等活动
         </p>
        </td>
        <td>
         <p>
          3 (4.2%)
         </p>
        </td>
        <td>
         <p>
          1 (2.8%)
         </p>
        </td>
        <td>
         <p>
          2 (5.6%)
         </p>
        </td>
        <td/>
       </tr>
       <tr>
        <td>
         <p>
          食欲-SNAQ
         </p>
        </td>
        <td/>
        <td>
         <p>
          15.2 (2.0)
         </p>
        </td>
        <td>
         <p>
          14.7 (2.0)
         </p>
        </td>
        <td>
         <p>
          15.8 (1.9)
         </p>
        </td>
        <td>
         <p>
          0.046*
         </p>
        </td>
       </tr>
       <tr>
        <td colspan="6">
         <p>
          认知（CANTAB）
         </p>
        </td>
       </tr>
       <tr>
        <td rowspan="2">
         <p>
          执行功能
         </p>
        </td>
        <td>
         <p>
          OTS-平均延迟（反应速度；ms）
         </p>
        </td>
        <td>
         <p>
          32773.2 (20028.7)
         </p>
        </td>
        <td>
         <p>
          37476.2 (24711.6)
         </p>
        </td>
        <td>
         <p>
          28766.9 (14250.0)
         </p>
        </td>
        <td>
         <p>
          0.130
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          空间工作记忆（错误次数）
         </p>
        </td>
        <td>
         <p>
          14.3 (10.0)
         </p>
        </td>
        <td>
         <p>
          13.0 (8.7)
         </p>
        </td>
        <td>
         <p>
          15.3 (11.0)
         </p>
        </td>
        <td>
         <p>
          0.420
         </p>
        </td>
       </tr>
       <tr>
        <td rowspan="4">
         <p>
          记忆
         </p>
        </td>
        <td>
         <p>
          PAL：第一次尝试记忆评分
         </p>
        </td>
        <td>
         <p>
          11.9 (4.6)
         </p>
        </td>
        <td>
         <p>
          12.5 (4.5)
         </p>
        </td>
        <td>
         <p>
          11.4 (4.7)
         </p>
        </td>
        <td>
         <p>
          0.430
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          PAL：总错误次数
         </p>
        </td>
        <td>
         <p>
          18.0 (16.2)
         </p>
        </td>
        <td>
         <p>
          16.7 (15.9)
         </p>
        </td>
        <td>
         <p>
          19.2 (16.7)
         </p>
        </td>
        <td>
         <p>
          0.580
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          图案识别记忆（% 正确）
         </p>
        </td>
        <td>
         <p>
          89.5 (10.5)
         </p>
        </td>
        <td>
         <p>
          87.0 (11.7)
         </p>
        </td>
        <td>
         <p>
          91.7 (9.0)
         </p>
        </td>
        <td>
         <p>
          0.110
         </p>
        </td>
       </tr>
       <tr>
        <td>
         <p>
          空间跨度（前向跨度长度；范围 2-9）
         </p>
        </td>
        <td>
         <p>
          5.7 (1.3)
         </p>
        </td>
        <td>
         <p>
          5.9 (1.6)
         </p>
        </td>
        <td>
         <p>
          5.5 (1.0)
         </p>
        </td>
        <td>
         <p>
          0.350
         </p>
        </td>
       </tr>
       <tr>
        <td/>
        <td>
         <p>
          缺失认知数据
         </p>
        </td>
        <td>
         <p>
          22
         </p>
        </td>
        <td>
         <p>
          13
         </p>
        </td>
        <td>
         <p>
          9
         </p>
        </td>
        <td/>
       </tr>
      </tbody>
     </table>
     <table-wrap-foot>
      <p>
       连续数据以均值（标准差）表示，分类数据以
       <italic>
        n
       </italic>
       （%）表示。* 表示显著性。缺失数据数仅列出认知数据；其他变量无缺失数据。
       <italic>
        p
       </italic>
       值是使用双侧配对
       <italic>
        t
       </italic>
       检验进行的研究臂之间的比较。
      </p>
      <p>
       <italic>
        SPPB
       </italic>
       短距离身体表现评分，
       <italic>
        IPAQ
       </italic>
       国际身体活动问卷，
       <italic>
        MET
       </italic>
       代谢当量任务（一项MET是您在休息时消耗的能量），
       <italic>
        SNAQ
       </italic>
       简化营养评估问卷，
       <italic>
        CANTAB
       </italic>
       剑桥神经心理学测试自动化电池，
       <italic>
        OTS
       </italic>
       一次触摸剑桥认知测试，
       <italic>
        PAL
       </italic>
       配对联想学习。
      </p>
     </table-wrap-foot>
    </table-wrap>
   </p>
   <p id="Par10">
    补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S4
    </xref>
    显示了参与者在研究基线和研究结束时使用myfood24在线软件记录的饮食数据。补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S5
    </xref>
    显示了相同的数据，但从分析中删除了过量报告者。没有发现任何低报告者。补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    按研究臂呈现了饮食数据。在基线或研究结束时，益生元和安慰剂组之间没有任何纤维摄入量的差异。总体而言，基线和研究结束之间的能量摄入量略有减少，这似乎是由益生元组的减少所驱动的（-132.4千卡/天）。益生元和安慰剂组之间的这一小差异（75.6千卡/天）在能量摄入量的测量误差范围内。这种小的能量摄入量减少的影响随着时间的推移，可能通过菊粉对食欲的影响而产生，可能会对肌肉力量产生影响。然而，我们意识到，即使使用自由生活个体中的金标准饮食记录技术，也很难测量如此小的能量摄入量变化。两臂之间的体重（千克）或身体质量指数在基线和研究结束之间没有显著差异（补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S6
    </xref>
    ）
    <sup>
     <xref ref-type="bibr" rid="CR29">
      29
     </xref>
     ,
     <xref ref-type="bibr" rid="CR30">
      30
     </xref>
    </sup>
    。
   </p>
   <p id="Par11">
    补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S7
    </xref>
    显示了肠道习惯问卷的结果，未发现干预组之间在任何与肠道习惯相关的问题上的差异。补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    显示了那些不合格或拒绝参加的人与那些参加的人的 демограф特征，使用现有的TwinsUK纵向数据。该队列以女性为主，历史原因使然。参与者较年轻，男性比例高于更广泛的TwinsUK队列。在调整性别差异为年龄和年龄差异为性别后，保留了显著差异（补充表
    <xref ref-type="supplementary-material" rid="MOESM1">
     S1
    </xref>
    ）。
   </p>
   <sec id="Sec3">
    <title>
     不良事件和依从性
    </title>
    <p id="Par12">
     益生元臂中轻度不良事件（如腹胀）的发生率高于安慰剂臂，但两者在依从性方面没有差异，表明补充剂总体上耐受性良好。没有参与者报告‘胃肠道副作用’作为不遵守研究干预的原因，两臂均无严重不良事件发生。
    </p>
    <p id="Par13">
     表
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     总结了每个手臂的不良事件数量和对干预措施的依从性。补充表
     <xref ref-type="supplementary-material" rid="MOESM1">
      S2
     </xref>
     列出了参与者报告的所有不良事件。我们还记录了在研究期间的药物变化（表
     <xref ref-type="table" rid="Tab2">
      2
     </xref>
     ），这些变化相对较少。
     <table-wrap id="Tab2">
      <label>
       表 2
      </label>
      <caption xml:lang="zh-CN">
       <p>
        PROMOTe 不良事件、药物变化、依从性和退出情况按研究臂划分
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th/>
         <th>
          <p>
           总计
          </p>
         </th>
         <th>
          <p>
           益生元组
          </p>
         </th>
         <th>
          <p>
           对照组
          </p>
         </th>
         <th>
          <p>
           <italic>
            p
           </italic>
           -值
          </p>
         </th>
        </tr>
        <tr>
         <th/>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 72
          </p>
         </th>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 36
          </p>
         </th>
         <th>
          <p>
           <italic>
            N
           </italic>
           = 36
          </p>
         </th>
         <th/>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td>
          <p>
           退出研究
           <italic>
            n
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           4 (6%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           1
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           不良事件
           <italic>
            n
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           10 (7%)
          </p>
         </td>
         <td>
          <p>
           8 (22%)
          </p>
         </td>
         <td>
          <p>
           2 (6%)
          </p>
         </td>
         <td>
          <p>
           0.041*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           药物变化
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           7/60 (12%)
          </p>
         </td>
         <td>
          <p>
           2/29 (7%)
          </p>
         </td>
         <td>
          <p>
           5/31 (16%)
          </p>
         </td>
         <td>
          <p>
           0.270
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           <italic>
            依从性
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           锻炼
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           59/59 (100%)
          </p>
         </td>
         <td>
          <p>
           30/30 (100%)
          </p>
         </td>
         <td>
          <p>
           28/29 (97%)
          </p>
         </td>
         <td>
          <p>
           –
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           袋装
           <italic>
            n
           </italic>
           /
           <italic>
            N
           </italic>
           (%)
          </p>
         </td>
         <td>
          <p>
           59/59 (100%)
          </p>
         </td>
         <td>
          <p>
           30/30 (100%)
          </p>
         </td>
         <td>
          <p>
           29/29 (100%)
          </p>
         </td>
         <td>
          <p>
           –
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           袋装计数，% 依从性均值（SD）
          </p>
         </td>
         <td>
          <p>
           78.7% (9.6)
          </p>
         </td>
         <td>
          <p>
           79.7% (10.5)
          </p>
         </td>
         <td>
          <p>
           77.5% (8.6)
          </p>
         </td>
         <td>
          <p>
           0.370
          </p>
         </td>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        数据以
        <italic>
         n
        </italic>
        (%) 表示。对于具有不完整数据的数据，这些数据以
        <italic>
         n
        </italic>
        /
        <italic>
         N
        </italic>
        (%) 表示。
        <italic>
         p
        </italic>
        值是使用双侧配对
        <italic>
         t
        </italic>
        检验进行的研究臂之间的比较。* 表示统计学显著性。
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
   </sec>
   <sec id="Sec4">
    <title>
     主要和次要结果
    </title>
    <p id="Par14">
     线性混合模型的主要和次要结果如表
     <xref ref-type="table" rid="Tab3">
      3
     </xref>
     所示，包括意向治疗（ITT）和按原议治疗（PP）分析。ITT 和 PP 模型之间的结果没有显著差异。对于椅子起立时间的主要结果，前生物素和安慰剂之间没有差异（平均变化为 0.88 s [SD 2.16] 对于前生物素和 1.12 s [SD 1.52] 对于安慰剂；
     <italic>
      p
     </italic>
     = 0.631），也没有对于身体表现的次要结果（握力、短身体表现电池和 IPAQ MET 分钟）或 SNAQ 食欲评分的差异。
     <table-wrap id="Tab3">
      <label>
       表 3
      </label>
      <caption xml:lang="zh-CN">
       <p>
        主要和次要结果的线性混合效应模型结果
       </p>
      </caption>
      <table frame="hsides" rules="groups">
       <thead>
        <tr>
         <th colspan="2">
          <p>
           结果
          </p>
         </th>
         <th>
          <p>
           益生元组
          </p>
         </th>
         <th>
          <p>
           对照组
          </p>
         </th>
         <th colspan="6">
          <p>
           治疗效果（益生元组 = 参考组）
          </p>
         </th>
        </tr>
        <tr>
         <th colspan="2"/>
         <th/>
         <th/>
         <th colspan="3">
          <p>
           意向治疗
          </p>
         </th>
         <th colspan="3">
          <p>
           按原计划
          </p>
         </th>
        </tr>
       </thead>
       <tbody>
        <tr>
         <td colspan="2">
          <p>
           <italic>
            主要结果
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           系数
          </p>
         </td>
         <td>
          <p>
           95% CI
          </p>
         </td>
         <td>
          <p>
           <italic>
            p
           </italic>
           -值
          </p>
         </td>
         <td>
          <p>
           系数
          </p>
         </td>
         <td>
          <p>
           95% CI
          </p>
         </td>
         <td>
          <p>
           <italic>
            p
           </italic>
           -值
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           椅子起立时间（秒）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           0.58
          </p>
         </td>
         <td>
          <p>
           1.08,2.24
          </p>
         </td>
         <td>
          <p>
           0.494
          </p>
         </td>
         <td>
          <p>
           0.58
          </p>
         </td>
         <td>
          <p>
           1.08,2.24
          </p>
         </td>
         <td>
          <p>
           0.494
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           10.38 (3.21)
          </p>
         </td>
         <td>
          <p>
           10.24 (2.21)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           9.49 (2.89)
          </p>
         </td>
         <td>
          <p>
           9.12 (1.96)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           0.88 (2.16)
          </p>
         </td>
         <td>
          <p>
           1.12 (1.52)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           <italic>
            次要结果
           </italic>
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           握力（kg）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           1.22
          </p>
         </td>
         <td>
          <p>
           −2.43,4.86
          </p>
         </td>
         <td>
          <p>
           0.512
          </p>
         </td>
         <td>
          <p>
           1.22
          </p>
         </td>
         <td>
          <p>
           −2.43,4.86
          </p>
         </td>
         <td>
          <p>
           0.512
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           26.23 (9.33)
          </p>
         </td>
         <td>
          <p>
           25.52 (9.27)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           28.98 (11.64)
          </p>
         </td>
         <td>
          <p>
           29.14 (10.08)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           2.74 (10.76)
          </p>
         </td>
         <td>
          <p>
           3.45 (8.48)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           短距离身体表现评分（范围 0-12）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.13
          </p>
         </td>
         <td>
          <p>
           −0.56,0.30
          </p>
         </td>
         <td>
          <p>
           0.551
          </p>
         </td>
         <td>
          <p>
           −0.13
          </p>
         </td>
         <td>
          <p>
           −0.56,0.30
          </p>
         </td>
         <td>
          <p>
           0.551
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           10.88 (1.49)
          </p>
         </td>
         <td>
          <p>
           11.32 (1.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           11.12 (1.32)
          </p>
         </td>
         <td>
          <p>
           11.45 (0.81)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           0.24 (1.05)
          </p>
         </td>
         <td>
          <p>
           0.06 (1.01)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           IPAQ MET 分钟
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           194.43
          </p>
         </td>
         <td>
          <p>
           −111.39, 500.24
          </p>
         </td>
         <td>
          <p>
           0.213
          </p>
         </td>
         <td>
          <p>
           245.18
          </p>
         </td>
         <td>
          <p>
           −70.36, 560.73
          </p>
         </td>
         <td>
          <p>
           0.128
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           538.09 (596.87)
          </p>
         </td>
         <td>
          <p>
           769.30 (640.08)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           771.09 (594.28)
          </p>
         </td>
         <td>
          <p>
           1030.83 (648.33)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           256.06 (853.84)
          </p>
         </td>
         <td>
          <p>
           72.04 (866.41)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           食欲（SNAQ）（范围 4-20）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           0.19
          </p>
         </td>
         <td>
          <p>
           −0.54,0.92
          </p>
         </td>
         <td>
          <p>
           0.607
          </p>
         </td>
         <td>
          <p>
           0.24
          </p>
         </td>
         <td>
          <p>
           −0.51,0.99
          </p>
         </td>
         <td>
          <p>
           0.532
          </p>
         </td>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           14.79 (1.79)
          </p>
         </td>
         <td>
          <p>
           15.89 (1.76)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           14.71 (1.88)
          </p>
         </td>
         <td>
          <p>
           15.80 (2.00)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td colspan="2">
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           −0.01 (1.29)
          </p>
         </td>
         <td>
          <p>
           −0.01 (1.62)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="4">
          <p>
           认知（CANTAB）
          </p>
         </td>
         <td>
          <p>
           认知因子评分
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.48
          </p>
         </td>
         <td>
          <p>
           −0.81, −0.14
          </p>
         </td>
         <td>
          <p>
           0.014*
          </p>
         </td>
         <td>
          <p>
           −0.48
          </p>
         </td>
         <td>
          <p>
           −0.81, −0.14
          </p>
         </td>
         <td>
          <p>
           0.014*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           0.05 (1.00)
          </p>
         </td>
         <td>
          <p>
           −0.23 (0.94)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           0.59 (0.68)
          </p>
         </td>
         <td>
          <p>
           0.18 (0.60)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           0.40 (0.83)
          </p>
         </td>
         <td>
          <p>
           0.19 (0.70)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="8">
          <p>
           执行功能
          </p>
         </td>
         <td>
          <p>
           OTS-平均延迟（反应速度；ms）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           631.22
          </p>
         </td>
         <td>
          <p>
           −8910.33, 10171.76
          </p>
         </td>
         <td>
          <p>
           0.889
          </p>
         </td>
         <td>
          <p>
           631.22
          </p>
         </td>
         <td>
          <p>
           −8910.33, 10171.76
          </p>
         </td>
         <td>
          <p>
           0.889
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           37,837.29 (25230.98)
          </p>
         </td>
         <td>
          <p>
           28,318.90 (14707.45)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           32,737.31 (21417.24)
          </p>
         </td>
         <td>
          <p>
           26,555.30 (13306.24)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           −1.0e + 04 (13,978.77)
          </p>
         </td>
         <td>
          <p>
           −6594.90 (9405.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           空间工作记忆（错误次数）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −1.84
          </p>
         </td>
         <td>
          <p>
           −7.12,3.43
          </p>
         </td>
         <td>
          <p>
           0.457
          </p>
         </td>
         <td>
          <p>
           −1.84
          </p>
         </td>
         <td>
          <p>
           −7.12,3.43
          </p>
         </td>
         <td>
          <p>
           0.457
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           12.77 (8.89)
          </p>
         </td>
         <td>
          <p>
           15.13 (11.52)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           10.15 (6.39)
          </p>
         </td>
         <td>
          <p>
           11.23 (9.16)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           −3.08 (9.22)
          </p>
         </td>
         <td>
          <p>
           −5.46 (10.44)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td rowspan="16">
          <p>
           记忆
          </p>
         </td>
         <td>
          <p>
           PAL：第一次尝试记忆评分
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −1.95
          </p>
         </td>
         <td>
          <p>
           −4.43,0.52
          </p>
         </td>
         <td>
          <p>
           0.104
          </p>
         </td>
         <td>
          <p>
           −1.95
          </p>
         </td>
         <td>
          <p>
           −4.43,0.52
          </p>
         </td>
         <td>
          <p>
           0.104
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           12.41 (4.64)
          </p>
         </td>
         <td>
          <p>
           10.88 (4.44)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           14.54 (3.99)
          </p>
         </td>
         <td>
          <p>
           12.69 (3.38)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           1.77 (4.53)
          </p>
         </td>
         <td>
          <p>
           0.77 (4.19)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           PAL：总错误次数
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           7.55
          </p>
         </td>
         <td>
          <p>
           4.65, 10.46
          </p>
         </td>
         <td>
          <p>
           0.001*
          </p>
         </td>
         <td>
          <p>
           7.55
          </p>
         </td>
         <td>
          <p>
           4.65, 10.46
          </p>
         </td>
         <td>
          <p>
           0.001*
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           17.05 (16.13)
          </p>
         </td>
         <td>
          <p>
           20.67 (17.05)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           9.15 (7.05)
          </p>
         </td>
         <td>
          <p>
           12.23 (10.15)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           −5.15 (13.92)
          </p>
         </td>
         <td>
          <p>
           −5.00 (12.34)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           图案识别记忆（% 正确）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −3.00
          </p>
         </td>
         <td>
          <p>
           −9.40,3.40
          </p>
         </td>
         <td>
          <p>
           0.331
          </p>
         </td>
         <td>
          <p>
           −3.00
          </p>
         </td>
         <td>
          <p>
           −9.40,3.40
          </p>
         </td>
         <td>
          <p>
           0.331
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           86.74 (11.97)
          </p>
         </td>
         <td>
          <p>
           91.32 (9.35)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           97.44 (7.12)
          </p>
         </td>
         <td>
          <p>
           93.59 (7.72)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           8.33 (7.61)
          </p>
         </td>
         <td>
          <p>
           1.92 (9.71)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           空间跨度（前向跨度长度；范围 2–9）
          </p>
         </td>
         <td/>
         <td/>
         <td>
          <p>
           −0.86
          </p>
         </td>
         <td>
          <p>
           −1.97,0.26
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
         <td>
          <p>
           −0.86
          </p>
         </td>
         <td>
          <p>
           −1.97,0.26
          </p>
         </td>
         <td>
          <p>
           0.120
          </p>
         </td>
        </tr>
        <tr>
         <td>
          <p>
           基线
          </p>
         </td>
         <td>
          <p>
           5.91 (1.63)
          </p>
         </td>
         <td>
          <p>
           5.50 (1.06)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           研究结束
          </p>
         </td>
         <td>
          <p>
           6.69 (1.60)
          </p>
         </td>
         <td>
          <p>
           5.46 (0.66)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
        <tr>
         <td>
          <p>
           基线和研究结束之间的变化
          </p>
         </td>
         <td>
          <p>
           0.54 (1.56)
          </p>
         </td>
         <td>
          <p>
           −0.23 (1.09)
          </p>
         </td>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
         <td/>
        </tr>
       </tbody>
      </table>
      <table-wrap-foot>
       <p>
        益生元组 = 参考组 * 表示显著性。
       </p>
       <p>
        连续数据以均值（标准差）表示，分类数据以
        <italic>
         n
        </italic>
        （%）表示。所有线性混合模型都调整了基线 SNAQ 评分。
       </p>
       <p>
        <italic>
         CI
        </italic>
        置信区间，
        <italic>
         SPPB
        </italic>
        短距离身体表现评分，
        <italic>
         IPAQ
        </italic>
        国际身体活动问卷，
        <italic>
         MET
        </italic>
        代谢当量任务（一项MET是您在休息时消耗的能量），
        <italic>
         SNAQ
        </italic>
        简化营养评估问卷，
        <italic>
         CANTAB
        </italic>
        剑桥神经心理学测试自动化电池，
        <italic>
         OTS
        </italic>
        一次触摸剑桥认知测试，
        <italic>
         PAL
        </italic>
        配对联想学习。
       </p>
      </table-wrap-foot>
     </table-wrap>
    </p>
    <p id="Par15">
     前生物素组在认知第一因子评分方面显示出显著改善，相比安慰剂（
     <italic>
      β
     </italic>
     = −0.482；95% CI −0.813，−0.141；
     <italic>
      p
     </italic>
     = 0.014）。此外，特定的认知测试配对联想学习（一种记忆测试）在前生物素组中错误次数显著较少，相比安慰剂（
     <italic>
      β
     </italic>
     = 7.55；95% CI：4.65–10.46；
     <italic>
      p
     </italic>
     = 0.001）。这种特定的认知测试具有临床意义，因为它已被确定为阿尔茨海默病痴呆的早期识别指标
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ，
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     。CANTAB 认知测试的缺失数据比其他结果变量更高。比较完成认知测试和未完成认知测试的参与者的人口统计特征，没有发现显著差异，因此没有特定的特征预测认知测试的缺失，如补充表
     <xref ref-type="supplementary-material" rid="MOESM1">
      S3
     </xref>
     所示
     <sup/>
     。没有进行未计划的后验分析。
    </p>
   </sec>
   <sec id="Sec5">
    <title>
     肠道微生物群结果
    </title>
    <p id="Par16">
     除了次要的身体表现结果外，肠道微生物组成和功能也被分析并从粪便样本中获得。所有样本都获得了良好的测序数据，平均每个样本有 21.6M 的读取对，且最小有 11.7M 的读取对。（补充 Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S1
     </xref>
     ）。平均每个样本有 17.9M 的读取对可以映射到基因目录，代表平均 82.8% 的 HQNH 读取对（最小 = 68.5%，见补充表
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ），代表 1494 个 MGS。绝大多数样本都以
     <italic>
      Bacteroidaceae
     </italic>
     、
     <italic>
      Oscillospiraceae
     </italic>
     和
     <italic>
      Lachnospiraceae
     </italic>
     为主，且有一些个体间的变异性，如预期的那样。
    </p>
    <sec id="Sec6">
     <title>
      双胞胎微生物群相似性
     </title>
     <p id="Par17">
      研究的双胞胎对在研究开始和结束时的肠道微生物组成的相似性被调查，并进行了遗传分析（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S2
      </xref>
      ）。虽然有证据表明双胞胎对之间的肠道微生物组成存在差异（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S3
      </xref>
      ），但我们发现双胞胎对的肠道微生物组成在研究开始和结束时都比无关个体的肠道微生物组成更为相似（
      <italic>
       U
      </italic>
      = 55579，
      <italic>
       p
      </italic>
      = 0.0026 和
      <italic>
       U
      </italic>
      = 44342，
      <italic>
       p
      </italic>
      = 0.00072），使用 Bray–Curtis 相似性（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S4
      </xref>
      ）。
     </p>
     <p id="Par18">
      尽管曼恩-惠特尼
      <italic>
       U
      </italic>
      测试比较双胞胎对和非双胞胎对的 p 值在两个时间点都显著，但进行了额外的统计分析以验证这些发现是否不是由于非双胞胎组中成对观察的数量过大。对于 35 对双胞胎的比较，比较两个非双胞胎（35 *（35-1）/ 2 = 595 个观察）比比较两个双胞胎（35 个观察）有更多的观察，这会由于非双胞胎组中观察的数量过大而损害简单的统计两组比较的有效性。因此，使用了一个排列法来评估所获得的组比较的测试统计量是否显著不同于通过随机排列观察的标签获得的测试统计量分布（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S5
      </xref>
      ）。对于基线和研究结束，比较真实测试统计量和从排列中获得的测试统计量分布的
      <italic>
       p
      </italic>
      值基本为零（曼恩-惠特尼
      <italic>
       U
      </italic>
      测试，
      <italic>
       P
      </italic>
      = 3.33 * 10 和 3.33 * 10，分别为基线和研究结束），表明微生物群落组成在双胞胎对内比在不同双胞胎对之间的两个个体更为相似
      <sup/>
      。
     </p>
    </sec>
    <sec id="Sec7">
     <title>
      前生素和安慰剂之间的微生物群
     </title>
     <p id="Par19">
      在基线时，使用 PERMANOVA评估，预生物和安慰剂组之间没有显著不同的微生物群落特征。Fig.
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      显示了研究结束时组间的比较，揭示了 11 个显著差异，主要是由于预生物组中
      <italic>
       Bifidobacterium
      </italic>
      的相对丰度较高，包括从门水平到属水平的 Actinobacteria，Firmicutes 和 Bacteroidetes 的小幅增加，以及
      <italic>
       Phocea massiliensis
      </italic>
      物种及其同源属的减少。此外，Fig.
      <xref ref-type="fig" rid="Fig2">
       2
      </xref>
      显示了在研究结束时比较预生物和安慰剂组的相对丰度时，调整基线丰度和双胞胎对，发现了 15 个显著不同的微生物群落特征。除了交叉分析中观察到的
      <italic>
       Bifidobacterium
      </italic>
      增加和
      <italic>
       P. massiliensis
      </italic>
      减少的主要效应外，预生物组还具有
      <italic>
       Anaeromassilibacillus
      </italic>
      的相对丰度较低和一些高级分类群，如 Deltaproteobacteria、Lactobacillales 和 Eubacteriales。
      <fig id="Fig2" position="float">
       <label>
        Fig. 2
       </label>
       <caption xml:lang="zh-CN">
        <title>
         双胞胎配对组间的益生元和安慰剂补充剂比较，包括研究结束时的数据或基线和研究结束时的差异。
        </title>
        <p>
         研究arms之间的细菌taxa相对丰度（a）和普遍性（p）的配对组比较，包括研究结束时的数据或基线和研究结束时的差异。微生物组taxon丰度差异的测试采用了基于LinDA的线性回归框架，具有组成偏差校正。基线或肠道代谢模块、肠脑模块或α多样性之间的组间没有显著差异。效应大小是线性模型中的偏差校正系数，其中正效应大小（蓝色）表示安慰剂组的水平更高，负效应大小（红色）表示益生元组的水平更高。
        </p>
       </caption>
       <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig2_HTML.png" mime-subtype="PNG" specific-use="web"/>
      </fig>
     </p>
     <p id="Par20">
      预生物和安慰剂组在任何 alpha 多样性措施方面都没有显著差异。使用 PERMANOVA评估，研究结束时预生物和安慰剂组在 beta 多样性方面也没有显著差异。成对的 beta 多样性差异在研究结束时没有发现比研究基线时更高（
      <italic>
       V
      </italic>
      = 102；
      <italic>
       p
      </italic>
      = 0.58）。补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S7
      </xref>
      显示了双胞胎对之间的 Bray-Curtis 差异比较，包括按合子性分组。
     </p>
     <p id="Par21">
      在基线和研究结束时进行组内比较时，预生物组有 40 个显著不同的特征，而安慰剂组只有
      <italic>
       Actinomyces graevenitzii
      </italic>
      的相对丰度显著不同（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S6
      </xref>
      ）。
     </p>
    </sec>
    <sec id="Sec8">
     <title>
      微生物群特征和肌肉力量
     </title>
     <p id="Par22">
      在一个调整了组和双胞胎对相关效应的组成偏差校正线性模型中，129 个微生物群落特征与椅子起立时间显著相关，包括 95 个微生物_taxa、32 个微生物功能以及丰富度和 Faith 的系统发育多样性（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S8
      </xref>
      ）。相关分析（使用中心对数比转换的丰度的 Pearson 相关系数）显示，椅子起立时间的变化与微生物群落特征的变化之间存在相关性，分析所有参与者，发现椅子起立时间的改善与丰富度的变化（
      <italic>
       r
      </italic>
      = -0.347；
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0159）、Shannon 多样性（
      <italic>
       r
      </italic>
      = -0.250；
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0486）和 Faith 多样性（
      <italic>
       r
      </italic>
      = -0.297；
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0275）之间存在相关性（补充 Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      ）。这里呈现的
      <italic>
       p
      </italic>
      值已经调整了多重测试。
     </p>
    </sec>
    <sec id="Sec9">
     <title>
      微生物群特征和认知功能
     </title>
     <p id="Par23">
      使用上述分析身体能力（椅子起立时间）和微生物群特征相关性的方法，我们观察到五个微生物群特征在调整手臂和双胞胎对相关效应以及纠正分类丰度的组成效应后，与认知能力（认知因子评分）显著相关（补充Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S10
      </xref>
      ）。这包括了放线菌门（
      <italic>
       r
      </italic>
      = −0.323；
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0447），在研究结束时，预生物群组中其相对丰度显著增加。认知因子评分改善与从基线到研究结束的Veillonellaceae和其同系顺序Veillonelalles的相对丰度增加之间也存在相关性（
      <italic>
       r
      </italic>
      = 0.585，
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0555，和
      <italic>
       r
      </italic>
      = 0.543，
      <italic>
       p
      </italic>
      <sub>
       adj
      </sub>
      = 0.0772，分别（补充Fig.
      <xref ref-type="supplementary-material" rid="MOESM1">
       S9
      </xref>
      ）。
     </p>
    </sec>
   </sec>
  </sec>
  <sec id="Sec10" sec-type="discussion">
   <title>
    讨论
   </title>
   <p id="Par24">
    衰老与增加的脆弱性和认知功能下降有关，两者都可能涉及肠道微生物群的作用。在这项随机对照试验中，我们证明预生物质通常耐受性良好，并导致肠道微生物群的变化，特别是双歧杆菌的相对丰度增加。尽管如此，预生物质和安慰剂之间的椅子起立时间的主要结果没有显著差异，但是预生物质改善了认知功能与安慰剂相比。
   </p>
   <sec id="Sec11">
    <title>
     肌肉力量和功能
    </title>
    <p id="Par25">
     我们没有发现这项预生物质在12周的时间内改善了肌肉力量与安慰剂相比，特别是我们的主要结果椅子起立时间。此外，预生物质对其他与肌肉力量和功能相关的次要结果没有影响，包括手握力、SPPB或身体活动（IPAQ）。
    </p>
    <p id="Par26">
     12周的干预期是基于以前的预生物质干预研究
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
      ，
      <xref ref-type="bibr" rid="CR33">
       33
      </xref>
     </sup>
     。然而，没有一项研究以肌肉力量作为主要结果。这个时间框架可能不足以让肌肉重塑发生，可能需要更长的干预期来欣赏肠道微生物群调节对肌肉健康的影响。虽然EWGSOP2指南推荐椅子起立时间作为肌肉力量的衡量标准，但未来的工作应该考虑添加一个可以检测肌肉中微妙变化的等长肌肉力量衡量标准（例如，股四头肌），除了椅子起立时间。虽然椅子起立时间被认为是老年人高度相关的功能性指标，但它是一个复合指标，依赖于力量、平衡、视力等，并且是一个代理指标而不是力量的直接衡量标准。老年人肌肉力量的衡量标准中存在广泛的变异性，尽管椅子起立时间和手握力等衡量标准在临床环境中容易实施，但在未来研究中，应该考虑更详细和直接的力量衡量标准，以证明肠道微生物群调节对老年人肌肉结果的改善
     <sup>
      <xref ref-type="bibr" rid="CR34">
       34
      </xref>
     </sup>
     。
    </p>
    <p id="Par27">
     此外，我们的样本量计算是基于以前使用椅子起立时间作为主要结果的试验
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ，
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ，
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
     </sup>
     。然而，没有一项试验使用过微生物群干预，因此可能该研究的样本量不足。确实，只有五分之一（14/65；预生物质组8例，安慰剂组6例，
     <italic>
      p
     </italic>
     = 0.68）的参与者在基线和研究结束时都测量了椅子起立时间，达到20%的改善，这是样本量计算中使用的预计改善值。
    </p>
    <p id="Par28">
     预生物剂的剂量基于同一干预措施在养老院居民中的试验
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     。Tandon等人（2019年）研究了年轻成年人中果聚糖（FOS）的剂量，并报告了2.5 g/d、5 g/d和10 g/d剂量对肠道微生物群落变化没有统计学意义的差异（PROMOTe袋含有7.5 g/d），但是最高剂量组中
     <italic>
      乳酸杆菌
     </italic>
     的丰度趋势存在差异
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
     </sup>
     。So等人进行了膳食纤维干预的meta分析，其中许多研究包括菊粉和/或FOS，并注意到不同剂量对
     <italic>
      双歧杆菌
     </italic>
     丰度的影响没有差异
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     。他们假设
     <italic>
      双歧杆菌
     </italic>
     可能存在对纤维的发酵限制，或者缺乏剂量-反应效应可能归因于基线的百分比增加而不是干预剂量
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     。这里呈现的结果表明7.5 g/d的剂量足以在肠道微生物群落中引起变化。然而，关于预生物剂在肌肉力量等身体结果方面的足够剂量，目前没有文献。可能剂量虽然足以在肠道微生物群落中引起变化，但不足以在健康志愿者队列中提供有关肌肉力量的临床重要反应。
    </p>
    <p id="Par29">
     最后，虽然本试验中使用的预生物剂已被证明可以改善老年参与者的握力、疲劳水平和脆弱性指数，但可能菊粉/FOS预生物剂不是影响肌肉健康的最佳预生物剂，需要进一步研究来确定这一目标的最佳预生物剂
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
      ,
      <xref ref-type="bibr" rid="CR26">
       26
      </xref>
     </sup>
     。
    </p>
   </sec>
   <sec id="Sec12">
    <title>
     认知功能
    </title>
    <p id="Par30">
     在次要结果方面，预生物剂改善了认知功能与安慰剂相比。通过使用因子得分来组合CANTAB认知电池的组成部分，很难报告这种改善是否具有临床意义。预生物剂组与安慰剂组中唯一具有显著改善的个体认知测试是配对联想学习测试中的错误次数，这是一种专注于视觉记忆和新学习的记忆测试
     <sup>
      <xref ref-type="bibr" rid="CR40">
       40
      </xref>
     </sup>
     。这种措施也已被确定为一种早期的疾病现象标志，例如阿尔茨海默病
     <sup>
      <xref ref-type="bibr" rid="CR31">
       31
      </xref>
      ,
      <xref ref-type="bibr" rid="CR32">
       32
      </xref>
     </sup>
     。
    </p>
    <p id="Par31">
     肠脑轴的概念，微生物群落影响双向肠脑通路，近年来已被确立
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR42">
       42
      </xref>
     </sup>
     。人们认为这种双向通信有三种主要途径：神经、免疫和内分泌
     <sup>
      <xref ref-type="bibr" rid="CR41">
       41
      </xref>
      ,
      <xref ref-type="bibr" rid="CR43">
       43
      </xref>
      ,
      <xref ref-type="bibr" rid="CR44">
       44
      </xref>
     </sup>
     。确实，有越来越多的证据支持针对肠道微生物群落（包括预生物剂）的干预措施以改善认知功能
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     。Desmedt等人回顾了预生物剂对人类情绪和认知的干预研究，发现14项研究具有广泛的方法论、结果、预生物剂剂量和干预持续时间的差异
     <sup>
      <xref ref-type="bibr" rid="CR27">
       27
      </xref>
     </sup>
     。大多数研究关注情绪和情感，但也有一些研究报告了言语记忆和识别的改善。没有任何研究使用CANTAB认知测试。因此，为了确认我们的发现，需要进行一项更大规模的研究，包括一系列认知测试，以及对效果和注意力的测量，以及详细的微生物群落测量（组成和功能）。
    </p>
   </sec>
   <sec id="Sec13">
    <title>
     肠道微生物群
    </title>
    <p id="Par32">
     重要的是，预生物剂干预影响了肠道微生物群落的组成和功能。预生物剂组中有40个微生物特征在基线和研究结束之间发生了变化，而安慰剂组中只有一个发生了变化（补充Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S6
     </xref>
     ）。这些特征包括α多样性和细菌分类的相对丰度。预生物剂组中观察到α多样性的减少，这与其他研究团队的发现一致
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="CR45">
       45
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
     </sup>
     。预生物剂倾向于增加某些分类的丰度，而不是增加多样性，如Fig.
     <xref ref-type="fig" rid="Fig2">
      2
     </xref>
     和补充Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S6
     </xref>
     所示，这可能导致多样性的减少。预生物剂组中
     <italic>
      放线菌门
     </italic>
     的相对丰度显著增加，特别是
     <italic>
      双歧杆菌
     </italic>
     ，与安慰剂组相比，这与其他研究中使用FOS和/或菊粉预生物剂的结果一致
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
      ,
      <xref ref-type="bibr" rid="CR46">
       46
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR50">
       50
      </xref>
     </sup>
     。值得注意的是，没有观察到
     <italic>
      乳酸杆菌
     </italic>
     或
     <italic>
      面肠杆菌
     </italic>
     的增加，这两种细菌在预生物剂补充研究中已被其他研究报道，特别是菊粉型果聚糖，而预生物剂组中这两种分类的同源顺序，乳酸杆菌目和厚壁菌目，相对于安慰剂组而言丰度增加，表明密切相关的分类也可能发挥作用
     <sup>
      <xref ref-type="bibr" rid="CR38">
       38
      </xref>
      ,
      <xref ref-type="bibr" rid="CR47">
       47
      </xref>
      ,
      <xref ref-type="bibr" rid="CR48">
       48
      </xref>
      ,
      <xref ref-type="bibr" rid="CR49">
       49
      </xref>
      ,
      <xref ref-type="bibr" rid="CR51">
       51
      </xref>
     </sup>
     。
    </p>
    <p id="Par33">
     有趣的是，尽管每对双胞胎中有一人接受益生元治疗，另一人接受安慰剂治疗，但在研究终点，双胞胎之间的差异性没有显著变化。以前的研究表明，肠道微生物群是由遗传和早期环境塑造的，社区生态学的早期播种和继承。因此，12周的益生元干预可能不足以改变双胞胎之间的相似性，因为他们共享遗传、早期环境暴露和许多其他因素。遗传力分析显示，我们发现的一些在干预过程中发生变化的taxa（例如
     <italic>
      Bifidobacterium
     </italic>
     ）是遗传的，这表明我们的研究设计通过使用双胞胎得到了加强，设计可能增加了检测效果的能力
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
      ,
      <xref ref-type="bibr" rid="CR53">
       53
      </xref>
      ,
      <xref ref-type="bibr" rid="CR54">
       54
      </xref>
      ,
      <xref ref-type="bibr" rid="CR55">
       55
      </xref>
     </sup>
     。
    </p>
    <p id="Par34">
     从肠道微生物的组成转移到其
     <italic>
      功能
     </italic>
     ，几种GMMs被发现与身体能力独立相关，独立于研究臂和双胞胎配对（补充Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S8
     </xref>
     ）。其中包括氨基酸和碳水化合物的代谢途径，以及磷酸戊糖途径；该途径提供氨基酸生物合成的前体和合成的中间体，对于骨骼肌合成至关重要
     <sup>
      <xref ref-type="bibr" rid="CR56">
       56
      </xref>
      <xref ref-type="bibr" rid="CR57">
       57
      </xref>
      ,
      <xref ref-type="bibr" rid="CR58">
       58
      </xref>
     </sup>
     。这一发现为肠道-肌肉轴假说提供了证据，该假说认为肠道微生物和骨骼肌之间存在双向链接，这可能对年龄相关的肌肉萎缩具有机制意义，并且需要在未来研究中进一步探讨肠道微生物群在年龄相关的骨骼肌合成阻力中的作用
     <sup>
      <xref ref-type="bibr" rid="CR18">
       18
      </xref>
     </sup>
     。
    </p>
    <p id="Par35">
     有越来越多的证据支持肠道-脑轴的存在，即中央和肠道神经系统之间的双向通信系统，其中肠道微生物群起着关键的影响作用
     <sup>
      <xref ref-type="bibr" rid="CR59">
       59
      </xref>
     </sup>
     。在这里，我们报告了认知因子评分增加和研究终点Actinobacteria相对丰度之间的正相关关系，即使在调整了基线丰度、研究臂和双胞胎配对之后（补充Fig.
     <xref ref-type="supplementary-material" rid="MOESM1">
      S10
     </xref>
     ）。Actinobacteria已被证明与认知功能有关，并已被证实与阿尔茨海默病和帕金森病有关
     <sup>
      <xref ref-type="bibr" rid="CR60">
       60
      </xref>
      ,
      <xref ref-type="bibr" rid="CR61">
       61
      </xref>
      <xref ref-type="bibr" rid="CR62">
       62
      </xref>
     </sup>
     。相关方向在不同研究中有所不同。虽然它已被证实与疾病状态有关，但有一项对39名成人的研究报告称，Actinobacteria丰度较高与运动速度和注意力改善有关
     <sup>
      <xref ref-type="bibr" rid="CR63">
       63
      </xref>
     </sup>
     。Actinobacteria是
     <italic>
      Bifidobacterium
     </italic>
     属的门；因此，值得注意的是，几项基于
     <italic>
      Bifidobacterium
     </italic>
     的益生菌干预研究显示了认知功能改善的希望
     <sup>
      <xref ref-type="bibr" rid="CR64">
       64
      </xref>
     </sup>
     。需要更多的研究来了解Actinobacteria和认知功能之间的联系。
    </p>
   </sec>
   <sec id="Sec14">
    <title>
     研究可行性
    </title>
    <p id="Par36">
     该临床试验的远程性是明显的优势，证明了远程交付的干预可以在老年人中成功实施，收集了大量的数据，并且具有良好的依从性。这种研究设计为提高老年人在研究中的代表性提供了希望。国家机构已经呼吁在临床研究中增加老年人的参与度，确定老年人为服务不足的群体，并承认旅行是他们参与的关键限制因素
     <sup>
      <xref ref-type="bibr" rid="CR65">
       65
      </xref>
      ,
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     。此外，招募的排除标准旨在尽可能地让老年人参与，包括那些生活在脆弱和多发病状态的人。
    </p>
    <p id="Par37">
     益生元组中观察到了更多的不良事件；然而，这些主要是预期的副作用，参与者事先已经被告知。两组之间的依从性没有差异，表明这些副作用没有影响依从性。因此，这项研究表明了向老年人群体提供相对廉价和商业上可用的肠道微生物群干预的可行性。未来的大规模研究可以使用更大的样本量、更长的干预期和可能不同的剂量方案来研究肠道微生物群介导骨骼肌对蛋白质的合成阻力在老年人的潜力。
    </p>
   </sec>
   <sec id="Sec15">
    <title>
     优势和局限性
    </title>
    <p id="Par38">
     该试验的一个关键优势是使用双胞胎对随机分配到每个研究臂，这导致了基线上非常匹配的臂，提高了检测有意义的效果的能力并减少了混杂。另外，设计是一项在队列内的实用性试验，这导致了成功地招募了样本量并达到目标。
    </p>
    <p id="Par39">
     远程研究设计是一种优势，因为在后COVID-19研究格局中，需要创新性的试验设计，以减少老年参与者的旅行需求，他们可能不愿意去医院或有行动不便的问题。远程试验也可能导致研究成本降低。然而，远程交付可能会排除那些不具备数字素养或没有计算机/平板电脑和/或互联网访问权限的人。这可能会不成比例地影响那些受教育水平较低、贫困程度较高、英语作为第二语言以及其他相关因素的人
     <sup>
      <xref ref-type="bibr" rid="CR66">
       66
      </xref>
     </sup>
     。数据收集也可能不如在现场进行时那么精确，尽管使用视频电话会议减少了这个问题。
    </p>
    <p id="Par40">
     远程设计导致无法测量肌肉质量，这是一种限制。虽然肌肉质量是老年人肌肉减退症（sarcopenia）的诊断特征之一，但欧洲老年人肌肉减退症工作组2（EWGSOP2）指南确实推荐肌肉力量作为最重要的识别因素
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     。未来研究应包括肌肉质量测量，以研究肠-肌肉轴的关系。
    </p>
    <p id="Par41">
     CANTAB认知测试的数据缺失率比其他结果变量高。这可能是由于在家中进行CANTAB测试的负担较大，需要花费时间，而且软件不兼容所有平板设备。一些使用平板设备的参与者无法使软件在其设备上运行。
    </p>
    <p id="Par42">
     肠道微生物群测量在两个时间点进行，分别是基线和研究结束。没有中期样本，我们无法评论微生物群在研究结束时的发现是否反映了对预生物素干预的部分恢复。可能需要更大的样本量和更长的干预时间来测试这一点。另外，本研究中肠道微生物群的功能分析是基于基因组数据而非直接测量。未来研究可以检查粪便的meta转录组学或代谢组学，以进一步研究这一点。麦芽糊精是预生物素试验中常用的对照物，但它有局限性，因为它不能直接与预生物素的能量匹配。未来试验可以使用能量匹配的对照物来克服这一点。
    </p>
    <p id="Par43">
     参与者来自TwinsUK队列，该队列历史上以女性为主，并具有健康志愿者偏见
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     。然而，它在很大程度上代表了英国人口
     <sup>
      <xref ref-type="bibr" rid="CR68">
       68
      </xref>
     </sup>
     。本研究旨在研究60岁以上的人群，因此不能推广到年轻人群。另外，参与者的女性多数性在一定程度上限制了推广性。未来在这一领域的工作应该包括中年成年人、最老年人和更多男性。Fig没有被翻译，因为根据要求，Fig不需要翻译。
    </p>
   </sec>
   <sec id="Sec16">
    <title>
     讨论总结
    </title>
    <p id="Par44">
     益生元改善了认知功能，但与安慰剂相比，没有影响健康老年双胞胎的肌肉力量和功能。我们的结果表明，廉价且易得的肠道微生物群介入措施有望改善我们老龄化人口的认知脆弱性。虽然这项试验没有证明骨骼肌力量的改善，但我们表明了在老年肌肉研究的背景下，通过益生元补充剂调节肠道微生物群是可行的，并且耐受性良好，且在肠道微生物群的组成和功能方面有明显的反应。未来的大规模试验可以研究使用肠道微生物群靶向介入措施来克服年龄相关的代谢阻力。我们还说明了远程交付试验对老年人的可行性，这为未来在这一领域的研究带来了希望，旨在减少老年人在临床试验中的代表性不足和降低研究成本。
    </p>
   </sec>
  </sec>
  <sec id="Sec17" sec-type="methods">
   <title>
    方法
   </title>
   <p id="Par45">
    该研究的设计在之前发表的方案中有详细描述
    <sup>
     <xref ref-type="bibr" rid="CR69">
      69
     </xref>
    </sup>
    。简而言之，PROMOTe（益生元和蛋白质对老年双胞胎肌肉的影响）试验是一项随机对照试验，双胞胎对（单卵和双卵）被随机分配到研究的两组中，每对双胞胎的一人被分配到一组。两组双胞胎都食用蛋白质（BCAA）补充剂粉末，其中一组还食用益生元补充剂（菊粉和果聚糖），而另一组食用安慰剂（麦芽糊精）。这些预混补充剂装在相同的袋子中，每位参与者被建议每天在同一时间将一袋补充剂溶解在水或其他饮料中。我们建议两组参与者都进行抗阻力训练。
   </p>
   <p id="Par46">
    该试验通过远程交付，使用邮寄包裹分发介入措施并从参与者收集测量数据和样本，使用各种技术，包括视频会议、在线问卷、在线认知测试和在线食物日记软件。这种远程研究设计部分是由于COVID-19大流行和相关的旅行限制，以及老年人可能对参加医院设置的担忧。另外，许多老年人由于各种原因难以旅行，国家卫生研究院呼吁创新研究设计以提高代表性不足群体（包括老年人）的包容性
    <sup>
     <xref ref-type="bibr" rid="CR66">
      66
     </xref>
     ,
     <xref ref-type="bibr" rid="CR70">
      70
     </xref>
    </sup>
    。这得到了老年人日益增长的互联网和技术素养的促进，这种素养在COVID-19大流行封锁期间得到了加速
    <sup>
     <xref ref-type="bibr" rid="CR71">
      71
     </xref>
     ,
     <xref ref-type="bibr" rid="CR72">
      72
     </xref>
    </sup>
    。
   </p>
   <p id="Par47">
    研究的流程和采取的措施如Fig.
    <xref ref-type="fig" rid="Fig3">
     3
    </xref>
    <sup/>
    所示。所有参与者都收到了一包邮寄包裹，包含所有必要的设备和指示，以采集生物样本，包括预付回邮信封、一个称为Kuptone的动力计（型号EH101）用于测量握力、一个四米长的ribbon用于辅助测量步行速度和一个用于估计身高的测量带。参与者在视频会议访问期间有机会向研究人员询问有关试验的任何方面的进一步指导。
    <fig id="Fig3" position="float">
     <label>
      Fig. 3
     </label>
     <caption xml:lang="zh-CN">
      <title>
       研究流程图。
      </title>
      <p>
       图注：此流程图以前已在研究方案中发表
       <sup>
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
       </sup>
       。经Ni Lochlainn等
       <sup>
        <xref ref-type="bibr" rid="CR70">
         70
        </xref>
       </sup>
       许可转载。
      </p>
     </caption>
     <graphic href="/ProjectMundo/MediaObjects/10X1038_s41467-024-46116-y/41467_2024_46116_Fig3_HTML.png" mime-subtype="PNG" specific-use="web"/>
    </fig>
   </p>
   <p id="Par48">
    性别数据基于参与者的自我报告。所有双胞胎都是同性别。性别身份没有被收集。参与者使用邮寄包裹中提供的测量带进行身高测量。如果参与者有体重秤，他们会被要求自行称重。体重秤可以使用标准的家庭用品（如一罐豆子）进行校准。短期身体表现电池测试（SPPB）在远程进行（包括椅子起立时间），并由一名受过训练的研究人员提供实时指示。手握力使用提供的动力计进行测量，并在视频通话期间由受过训练的研究人员提供指导。粪便样本由参与者自己使用提供的样本采集套件采集。双胞胎被要求收集一个“豌豆大小”的粪便样本到一个DNA/RNA Shield粪便采集管（Zymo Research）中，并将其邮寄到实验室。收到样本后，使用玻璃珠、旋转、离心和分装上清液进行暂时和长期储存于−80℃。所有样本使用定制的MagMax Core核酸纯化套件和MagMax Core机械裂解模块进行微生物DNA提取。该方案针对1g/ml的初始粪便重量和最终100μl的洗脱体积进行了优化。随后的DNA在−20℃下长期储存。微生物DNA被送到
    <italic>
     Clinical Microbiomics Ltd
    </italic>
    <sup/>
    进行肠道微生物群的特征化，使用shotgun metagenomic测序（见补充说明
    <xref ref-type="supplementary-material" rid="MOESM1">
     1
    </xref>
    的详细方法）。
   </p>
   <p id="Par49">
    认知测试从CANTAB电池中包括执行功能测试，特别是剑桥一触式袜子测试和空间工作记忆测试，以及记忆测试，特别是空间跨度、图案识别记忆和配对联想学习
    <sup>
     <xref ref-type="bibr" rid="CR40">
      40
     </xref>
    </sup>
    。三天的食物日记数据被输入和分析在
    <italic>
     MyFood24
    </italic>
    在线软件上
    <sup>
     <xref ref-type="bibr" rid="CR73">
      73
     </xref>
     ,
     <xref ref-type="bibr" rid="CR74">
      74
     </xref>
    </sup>
    。
   </p>
   <p id="Par50">
    如果参与者回答“您是否每天服用补充剂？”的问题为“是——每天”或“几乎每天”，则被认为是遵守补充剂的；如果参与者报告每周进行两次或以上的锻炼，则被认为是遵守锻炼的。最后，参与者被要求在最后一次视频访问时保留剩余的袋子，以便计算。这个数字与参与者开始研究的天数相比，计算出百分比的依从性。这项研究在ClinicalTrials.gov（NCT04309292）注册。
   </p>
   <sec id="Sec18">
    <title>
     纳入/排除标准
    </title>
    <p id="Par51">
     参与者必须满足以下条件：年龄60岁或以上，之前报告的饮食蛋白质摄入量低（
    </p>
   </sec>
   <sec id="Sec19">
    <title>
     研究干预
    </title>
    <p id="Par52">
     参与者被提供粉末形式的食物补充剂袋。所有袋子都包含3.32g的支链氨基酸蛋白粉，包括
     <sc>
      l
     </sc>
     -亮氨酸1660mg，
     <sc>
      l
     </sc>
     -异亮氨酸830mg和
     <sc>
      l
     </sc>
     -缬氨酸830mg。干预组的袋子还包含7.5g的益生元（Darmocare Pre®，Bonusan），由菊粉（最小3375mg）和果聚糖（FOS）（最小3488mg）组成。对照组的袋子包含7.5g的麦芽糊精粉。所有这些食物补充剂都可以在商店购买，不需要处方。益生元的选择是基于一项使用相同干预措施的试验，该试验显示老年人群中手握力和疲劳水平有所改善，两者都是Fried无力标准的两个指标
     <sup>
      <xref ref-type="bibr" rid="CR25">
       25
      </xref>
     </sup>
     。麦芽糊精常被用作肠道微生物和饮食干预研究的对照
     <sup>
      <xref ref-type="bibr" rid="CR39">
       39
      </xref>
     </sup>
     。
    </p>
    <p id="Par53">
     两个组的袋子都被制造成无法区分的袋子，只能通过随机数识别，这个随机数只能被国王临床试验单位（KCTU）访问，KCTU负责这项研究的随机化。随机化和臂部分配都是由KCTU远程完成的，KCTU发出相应的数字以便研究团队将正确的袋子发送给每个参与者。随机化是以双胞胎对为单位进行的，每对双胞胎作为一个固定单位，一个双胞胎被随机分配到每个臂部。所有参与者和研究人员在数据分析完成之前都被蒙蔽。Fig. 1、Fig. 2和Fig. 3未被翻译，因为您要求不翻译“Fig.”
    </p>
    <p id="Par54">
     所有参与者都被要求在试验期结束时保留任何剩余的袋子，以衡量其遵守性。最后，所有参与者都被鼓励在整个干预期间至少每周两次进行规律的抗阻力锻炼，并在研究开始时提供有关此事的书面建议，该建议可在英国国家卫生服务（NHS）网站上找到：
     <ext-link ext-link-type="uri" href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
      https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
     </ext-link>
     <sup>
      <xref ref-type="bibr" rid="CR75">
       75
      </xref>
     </sup>
     。抗阻力锻炼包括深蹲、提小腿、坐立、腿部抬举、腿部伸展、墙壁按压和二头肌卷曲。这些锻炼通常被推荐给老年人，可以在家中进行，并不代表大量的锻炼计划。在整个干预期间，每周都会发送短信提醒，以鼓励参与者遵守锻炼和补充剂的规定。
    </p>
   </sec>
   <sec id="Sec20">
    <title>
     结果
    </title>
    <p id="Par55">
     结果是在研究访问期间通过视频会议、远程完成问卷、3天的食物日记来衡量蛋白质和其他饮食摄入量（以控制混杂因素）以及认知测试电池，并通过邮寄方式从参与者那里收集生物样本。主要结果是椅子起立时间（不用手臂做5次椅子起立）的变化，在基线和研究结束时测量。椅子起立时间是短期身体表现电池的一部分，与生活质量、身体功能、虚弱、多发病和认知功能有关
     <sup>
      <xref ref-type="bibr" rid="CR76">
       76
      </xref>
      ,
      <xref ref-type="bibr" rid="CR77">
       77
      </xref>
     </sup>
     。这是欧洲老年人肌肉减退工作组2指导推荐的力量测量指标
     <sup>
      <xref ref-type="bibr" rid="CR67">
       67
      </xref>
     </sup>
     。
    </p>
    <p id="Par56">
     次要结果包括认知电池因子得分、短期身体表现电池（SPPB）得分（包括椅子起立时间和步行速度）、握力、步行速度、使用国际身体活动问卷（IPAQ）和简化营养评估问卷（SNAQ）测量的自我报告身体活动水平以及食欲得分。
    </p>
   </sec>
   <sec id="Sec21">
    <title>
     肠道微生物群
    </title>
    <p id="Par57">
     肠道微生物群落特征的完整方法论在补充说明1中提供
     <sup>
      <xref ref-type="supplementary-material" rid="MOESM1">
       1
      </xref>
     </sup>
     。总的来说，共有137个DNA样本被测序，平均每个样本有2160万（M）读取对（Illumina 2×150 PE）。去除了宿主污染，修剪了适配器和碱基，保留了通过过滤的读取对，长度至少为100bp；这些被归类为高质量非宿主读取对（HQNH）。82.8%的HQNH读取对被映射到临床微生物学人类肠道基因目录中，使用BWA mem（v. 0.7.17）
     <sup>
      <xref ref-type="bibr" rid="CR78">
       78
      </xref>
     </sup>
     。平均每个样本检测到326个基因组物种（MGSs）。为了对MGS进行 taxonomic 注释，其基因被比对到NCBI RefSeq原核基因组（2022-01-19）和nt（2021-08-03）数据库中，并使用等级特异性注释标准。通过对每个样本的固定数量的特征基因计数进行随机采样（不替换）计算了稀释的MGS丰度-profile。在本研究中，采样了431127个特征基因计数。使用EggNOG映射器（v. 2.0.1）、钻石模式和KEGG模块（v. 78.2）
     <sup>
      <xref ref-type="bibr" rid="CR79">
       79
      </xref>
      <xref ref-type="bibr" rid="CR80">
       80
      </xref>
     </sup>
     进行了微生物群落的功能注释和特征分析。
    </p>
    <p id="Par58">
     所有微生物群落分析都使用相对丰度进行组间比较，而α和β多样性估计则从通过随机采样读取对而创建的稀释丰度矩阵中计算。α多样性指标样本内多样性，而β多样性测度则是样本间相似性/差异性的估计
     <sup>
      <xref ref-type="bibr" rid="CR81">
       81
      </xref>
     </sup>
     。在每种数据类型中（例如，基因，MGS），所有样本都具有相同数量的信息丰富的测序读取对：MGS丰度的稀释是仅从映射到MGS特征基因的读取对中进行采样，而KEGG orthology（KO）丰度的稀释则仅从映射到具有分配KO的基因的读取对中进行采样。然而，基因丰度的稀释是通过对整个基因目录的读取对进行采样来完成的。α多样性被计算为检测到的微生物数量（丰富度），或基于自然对数的Shannon指数，或者是Faith的系统发育多样性。β多样性被计算为Bray–Curtis差异性和加权UniFrac距离。
    </p>
    <p id="Par59">
     双胞胎之间的相似性是使用曼恩-惠特尼
     <italic>
      U
     </italic>
     测试并将其与非双胞胎对进行比较，原因是多种内源性和环境因素（如饮食、地理位置、居住类型、同居状态和宿主基因）会影响宿主微生物群落
     <sup>
      <xref ref-type="bibr" rid="CR82">
       82
      </xref>
     </sup>
     。正式的遗传力分析使用了ACE模型，如所述，以确定微生物群落之间的相似性是否可以归因于微生物taxa的遗传力
     <sup>
      <xref ref-type="bibr" rid="CR52">
       52
      </xref>
     </sup>
     。
    </p>
   </sec>
   <sec id="Sec22">
    <title>
     样本大小计算
    </title>
    <p id="Par60">
     从TwinsUK队列现有的数据来看，我们观察到椅子上升时间近似于对数正态分布，log10（椅子上升时间）具有0.126的标准差。我们认为椅子上升时间相对减少20%既是合理的也是临床上重要的。我们基于以前使用椅子上升时间的研究，但是注意到没有研究在肠道微生物群落干预的背景下调查了这一问题。根据这些数据，我们计算出我们需要每组28名参与者（总共56名）才能达到80%的功效。允许20%的脱落，我们需要
     <italic>
      n
     </italic>
     = 70名参与者（每组35名）。使用双胞胎可以增加研究功效，因为基线时的匹配度高，基因和/或环境变异性减少，从而减少混杂变异
     <sup>
      <xref ref-type="bibr" rid="CR35">
       35
      </xref>
      ,
      <xref ref-type="bibr" rid="CR36">
       36
      </xref>
      ,
      <xref ref-type="bibr" rid="CR37">
       37
      </xref>
      <xref ref-type="bibr" rid="CR83">
       83
      </xref>
     </sup>
     。
    </p>
   </sec>
   <sec id="Sec23">
    <title>
     统计分析
    </title>
    <p id="Par61">
     分析使用Stata SE版本15.1进行，除了肠道微生物群落分析外，后者使用R版本4.2.1
     <sup>
      <xref ref-type="bibr" rid="CR84">
       84
      </xref>
      <xref ref-type="bibr" rid="CR85">
       85
      </xref>
     </sup>
     。随机化组的揭盲仅在所有统计分析完成后进行。所有分析中，双侧
     <italic>
      P
     </italic>
     值小于0.05被认为是显著的。参与者不会因缺失基线协变量数据而被排除，以满足意向性治疗（ITT）方法的原则。因此，对于此类别中的缺失数据，使用了均值插补技术。或者，对于某些变量，如果最近的值来自TwinsUK队列的纵向数据，并且被认为是在适当的时间范围内，则使用了最近的值。关于插补方法的决定是在揭盲之前做出的。
    </p>
    <p id="Par62">
     在缺失的结果数据方面，为了进行主要分析，假设缺失数据是随机缺失的，并且干预的效果在有和没有观察结果的个体中是相同的。没有发现缺失数据在每个治疗分配中不平衡的证据。
    </p>
    <p id="Par63">
     为了比较那些拒绝或不符合参加条件的人与那些参加的人，使用了TwinsUK队列现有的纵向数据。使用双侧配对t检验来比较每组。性别之间的差异经过年龄调整，年龄之间的差异经过性别调整，以评估哪一个变量驱动了两个组之间的差异。
    </p>
    <p id="Par64">
     为了在基线上描述研究组之间的差异，连续变量使用两样本
     <italic>
      t
     </italic>
     -检验进行比较，分类变量使用Pearson的χ²检验。两侧配对
     <italic>
      t
     </italic>
     -检验用于比较基线和研究结束之间的饮食数据。
    </p>
    <p id="Par65">
     为了研究认知功能的总体情况，使用因子分析得分来综合五项认知测试的结果（补充说明
     <xref ref-type="supplementary-material" rid="MOESM1">
      2
     </xref>
     ）。基线的因子载荷被应用于基线和研究结束的认知测试结果，以确保统一的载荷。从scree图中识别出一个因子，解释了最大方差。因此，基线和研究结束点的因子得分被推导出来，并随后用于混合效应模型中。线性混合效应模型被用于比较干预组（arm 1 vs arm 2；盲法）在每个结果上的变化，使用研究结束时的结果测量值，并在模型中包含基线测量值。双侧配对t检验被用于基线和干预结束之间的组内比较。双生子聚类被认为是随机效应，包括家庭标识符和zygosity，处理组被认为是固有效应。
    </p>
    <p id="Par66">
     为了检查营养摄入的过量和不足报告，Goldberg截断值被用于比较能量摄入与计算的基础代谢率比，并乘以1.4的因子来考虑身体活动
     <sup>
      <xref ref-type="bibr" rid="CR86">
       86
      </xref>
      ,
      <xref ref-type="bibr" rid="CR87">
       87
      </xref>
      <xref ref-type="bibr" rid="CR88">
       88
      </xref>
     </sup>
     。根据基线时参与者的IPAQ评分，选择了“轻度”职业活动水平。
    </p>
    <p id="Par67">
     肠道微生物特征（组成、功能、多样性指标、GMMs和GBMs）在基线和研究结束时使用Wilcoxon符号秩检验比较前生物和安慰剂研究组。另外，对每个组分别进行了基线和端点之间的组内比较。我们测试了任何微生物特征是否与主要结果椅子上升时间在基线、研究结束或两者之间的变化有关。微生物组特征的变化被输入到与椅子上升时间变化和认知因子得分变化的相关分析中。所有变化变量都是基线和研究结束点之间的差异。为了计算微生物特征的变化，使用了原始相对丰度，并且得到的delta值被中心对数比转换并用于线性模型的输入。
    </p>
    <p id="Par68">
     微生物（不）相似性的成对比较使用Mann-Whitney U检验。多变量方差分析（PERMANOVA）检验使用vegan R包中的adonis2函数进行，进行1000次置换。分析使用Benjamini-Hochberg方法调整多重测试，以控制假发现率在10%的水平。广义遗传力使用ACE模型（来自R包mets）确定。该模型估计表型变异中来自加性遗传效应（A）、共同环境（C）和每个双生子的独特环境（E）的比例。该模型分别适用于每个组中发现的超过2个样本的taxa的丰度（
     <italic>
      丰度
     </italic>
     ∼ 1），并用于提取广义遗传力。有关肠道微生物统计分析的更多细节，请参阅补充说明
     <xref ref-type="supplementary-material" rid="MOESM1">
      1
     </xref>
     <sup>
      <xref ref-type="bibr" rid="CR89">
       89
      </xref>
      <xref ref-type="bibr" rid="CR90">
       90
      </xref>
      ,
      <xref ref-type="bibr" rid="CR91">
       91
      </xref>
     </sup>
     。
    </p>
   </sec>
   <sec id="Sec24">
    <title>
     报告摘要
    </title>
    <p id="Par69">
     有关研究设计的更多信息，请参阅与本文链接的
     <xref ref-type="supplementary-material" rid="MOESM3">
      Nature Portfolio Reporting Summary
     </xref>
     。
    </p>
   </sec>
  </sec>
 </body>
 <back>
  <ack>
   <title>
    致谢
   </title>
   <p>
    作者们想感谢国家卫生研究院（National Institute of Health Research）为这项研究提供资金支持。我们还想感谢双胞胎研究部门的研究人员以及所有参与者。特别感谢Deborah Hart、Ayrun Nessa、Alyce Sheedy和Gulsah Akdag，他们为PROMOTe试验的进行做出了巨大的贡献。我们感谢双胞胎志愿者咨询小组（TwinsUK Volunteer Advisory Panel）对研究设计的深刻评论和反馈。我们还想感谢Roosa Varjus为微生物群分析做出的贡献。这项研究由伦敦国王学院（King's College London）和盖伊和圣托马斯医院国家卫生服务信托基金（Guy's and St Thomas' NHS Trust）共同赞助。两家赞助机构都没有参与研究设计、数据收集和分析或稿件写作。资金支持MNL获得了NIHR博士奖学金（grant code：NIHR300159）。C.J.S.获得了医学研究委员会（Medical Research Council）、威康信托基金（Wellcome Trust）（grant code：WT 212904/Z/18/Z）和慢性疾病研究基金会（Chronic Disease Research Foundation）的资金支持。K.W.获得了医学研究委员会、NIHR、克罗恩和结肠炎英国基金会（Crohn's and Colitis UK）、Kenneth Rainin基金会（Kenneth Rainin Foundation）、Leona M.和Harry B. Helmsley慈善信托基金（Leona M. and Harry B. Helmsley Charitable Trust）、杏仁委员会（Almond Board of California）、达能公司（Danone）和国际干果委员会（International Dried Fruit Council）的资金支持。双胞胎英国（TwinsUK）获得了威康信托基金、Wellcome LEAP、医学研究委员会、Versus Arthritis、工程与物理科学研究委员会（Engineering  Physical Sciences Research Council）、生物技术和生物科学研究委员会（Biotechnology and Biological Sciences Research Council）、欧洲委员会（European Commission）、慢性疾病研究基金会（Chronic Disease Research Foundation）、Zoe Ltd.、国家卫生和护理研究院（National Institute for Health and Care Research）临床研究网络（Clinical Research Network）和生物医学研究中心（Biomedical Research Centre）基于盖伊和圣托马斯医院国家卫生服务信托基金（Guy's and St Thomas' NHS Foundation Trust）与伦敦国王学院（King's College London）合作的资金支持。myfood24膳食报告软件在这项研究中被使用。myfood24是在医学研究委员会资金支持下开发的（grant G110235）。myfood24现在由 Dietary Assessment Ltd 公司支持。关于使用myfood24的请求应该发送到enquiries@myfood24.org。
   </p>
  </ack>
  <sec sec-type="author-contribution">
   <title>
    作者贡献
   </title>
   <p>
    M.N.L.、K.W.和C.J.S.设计了这项研究并撰写了方案，得到了R.C.E.B.、M.P.G、S.W.、A.F.B、A.N.、A.S.、G.A.、D.H.、C.M.、S.D.R.H.、A.A.W.和C.G.的输入。A.N.、A.S.、G.A.、D.H.和C.M.支持了临床试验，包括招募和/或管理患者。M.N.L.进行了统计分析，得到了C.J.S、K.W、R.C.E.B、P.T.S.和G.R.的输入。J.M.M.进行了微生物群分析，得到了M.N.L.、C.J.S.和R.C.E.B.的输入。M.N.L.、S.W.、A.F.B、A.N.和A.S.帮助收集了数据和样本。M.N.L.撰写了论文。所有作者都审阅了论文并批准了最终版本。
   </p>
  </sec>
  <sec sec-type="peer-review">
   <title>
    同行评议
   </title>
   <sec id="FPar1">
    <title>
     同行评议信息
    </title>
    <p id="Par70">
     <italic>
      Nature Communications
     </italic>
     thanks Edward Chambers, Ali Keshavarzian and Huang Lin for their contribution to the peer review of this work. A peer review file is available.
    </p>
   </sec>
  </sec>
  <sec sec-type="data-availability">
   <title>
    数据可用性
   </title>
   <p>
    The gut microbiome sequencing data generated in this study have been deposited in the European Nucleotide Archive (ENA) at EMBL-EBI under accession number
    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/browser/view/PRJEB72531">
     PRJEB72531
    </ext-link>
    . All other data are available on request from TwinsUK, and access can be obtained after approval by the TwinsUK Resource Executive Committee by following this link:
    <ext-link ext-link-type="uri" xlink:href="https://twinsuk.ac.uk/resources-for-researchers/access-our-data/">
     https://twinsuk.ac.uk/resources-for-researchers/access-our-data/
    </ext-link>
    .
   </p>
  </sec>
  <sec sec-type="data-availability">
   <title>
    代码可用性
   </title>
   <p>
    Stata code was utilised for data cleaning and analysis using Stata SE version 15.1
    <sup>
     <xref ref-type="bibr" rid="CR84">
      84
     </xref>
    </sup>
    . Gut microbiome analysis utilised R version 4.2.1
    <sup>
     <xref ref-type="bibr" rid="CR85">
      85
     </xref>
    </sup>
    , using R packages vegan (available from:
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/vegan/index.html">
     https://cran.r-project.org/web/packages/vegan/index.html
    </ext-link>
    ) and Mets (available from
    <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/web/packages/mets/index.html">
     https://cran.r-project.org/web/packages/mets/index.html
    </ext-link>
    ).
   </p>
  </sec>
  <sec sec-type="ethics-statement">
   <sec id="FPar2" sec-type="COI-statement">
    <title>
     竞争利益
    </title>
    <p id="Par71">
     C.J.S. has consulted for Zoe Limited for work on the Zoe Health Study. Janne Marie Moll is an employee of Clinical Microbiomics. K.W. is a co-inventor/patent holder for volatile organic compounds in the diagnosis and management of irritable bowel syndrome. The remaining authors declare no competing interests.
    </p>
   </sec>
   <sec id="FPar3">
    <title>
     伦理批准
    </title>
    <p id="Par72">
     The PROMOTe Study was approved by NHS North of Scotland Research Ethics Service (REC reference 21/NS/0045), IRAS ID 257415. This study was carried out under TwinsUK BioBank ethics, approved by North West—Liverpool Central Research Ethics Committee (REC reference 19/NW/0187), IRAS ID 258513. This approval supersedes earlier approvals granted to TwinsUK by the St Thomas’ Hospital Research Ethics Committee, later London—Westminster Research Ethics Committee (REC reference EC04/015), which have now been subsumed within the TwinsUK BioBank. Written informed consent was obtained from all participants. All research, therefore carried out in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
    </p>
   </sec>
  </sec>
  <ref-list id="Bib1">
   <title>
    参考文献
   </title>
   <ref-list>
    <ref id="CR1">
     <label>
      1.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kingston
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Is late-life dependency increasing or not? A comparison of the Cognitive Function and Ageing Studies (CFAS)
      </article-title>
      <source>
       Lancet
      </source>
      <year>
       2017
      </year>
      <volume>
       390
      </volume>
      <fpage>
       1676
      </fpage>
      <lpage>
       1684
      </lpage>
      <pub-id pub-id-type="pmid">
       28821408
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5640505
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/S0140-6736(17)31575-1
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR2">
     <label>
      2.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Arvanitakis
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <name>
        <surname>
         Shah
        </surname>
        <given-names>
         RC
        </given-names>
       </name>
       <name>
        <surname>
         Bennett
        </surname>
        <given-names>
         DA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Diagnosis and management of dementia: review
      </article-title>
      <source>
       J. Am. Med. Assoc.
      </source>
      <year>
       2019
      </year>
      <volume>
       322
      </volume>
      <fpage>
       1589
      </fpage>
      <pub-id pub-id-type="doi">
       10.1001/jama.2019.4782
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR3">
     <label>
      3.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harada
        </surname>
        <given-names>
         CN
        </given-names>
       </name>
       <name>
        <surname>
         Natelson Love
        </surname>
        <given-names>
         MC
        </given-names>
       </name>
       <name>
        <surname>
         Triebel
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Normal cognitive aging
      </article-title>
      <source>
       Clin. Geriatr. Med.
      </source>
      <year>
       2013
      </year>
      <volume>
       29
      </volume>
      <fpage>
       737
      </fpage>
      <lpage>
       752
      </lpage>
      <pub-id pub-id-type="pmid">
       24094294
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4015335
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cger.2013.07.002
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR4">
     <label>
      4.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sayer
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         A
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia definition, diagnosis and treatment: consensus is growing
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2022
      </year>
      <volume>
       51
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afac220
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR5">
     <label>
      5.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Mandolesi
        </surname>
        <given-names>
         L
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of physical exercise on cognitive functioning and wellbeing: biological and psychological benefits
      </article-title>
      <source>
       Front. Psychol.
      </source>
      <year>
       2018
      </year>
      <volume>
       9
      </volume>
      <fpage>
       509
      </fpage>
      <pub-id pub-id-type="pmid">
       29755380
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5934999
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fpsyg.2018.00509
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR6">
     <label>
      6.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Bowyer
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Steves
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Dietary protein and muscle in aging people: the potential role of the gut microbiome
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2018
      </year>
      <volume>
       10
      </volume>
      <fpage>
       929
      </fpage>
      <pub-id pub-id-type="pmid">
       30036990
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6073774
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu10070929
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR7">
     <label>
      7.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Welch
        </surname>
        <given-names>
         AA
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Nutritional influences on age-related skeletal muscle loss
      </article-title>
      <source>
       Proc. Nutr. Soc.
      </source>
      <year>
       2014
      </year>
      <volume>
       73
      </volume>
      <fpage>
       16
      </fpage>
      <lpage>
       33
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXitFylsL4%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24229650
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0029665113003698
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR8">
     <label>
      8.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Deutz
        </surname>
        <given-names>
         NEP
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group
      </article-title>
      <source>
       Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       33
      </volume>
      <fpage>
       929
      </fpage>
      <lpage>
       936
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXnslehtL0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24814383
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4208946
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.clnu.2014.04.007
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR9">
     <label>
      9.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cermak
        </surname>
        <given-names>
         NM
        </given-names>
       </name>
       <name>
        <surname>
         Res
        </surname>
        <given-names>
         PT
        </given-names>
       </name>
       <name>
        <surname>
         de Groot
        </surname>
        <given-names>
         LC
        </given-names>
       </name>
       <name>
        <surname>
         Saris
        </surname>
        <given-names>
         WHM
        </given-names>
       </name>
       <name>
        <surname>
         van Loon
        </surname>
        <given-names>
         LJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise training: a meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2012
      </year>
      <volume>
       96
      </volume>
      <fpage>
       1454
      </fpage>
      <lpage>
       1464
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC38XhslylsbfF
      </pub-id>
      <pub-id pub-id-type="pmid">
       23134885
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.112.037556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR10">
     <label>
      10.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Does lean red meat enhance the effetcs of exercise on muscle health and function in the elderly?
       <italic>
        Innov
       </italic>
      </article-title>
      <source>
       Aging
      </source>
      <year>
       2017
      </year>
      <volume>
       1
      </volume>
      <fpage>
       3
      </fpage>
      <lpage>
       4
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR11">
     <label>
      11.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Daly
        </surname>
        <given-names>
         RM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Protein-enriched diet, with the use of lean red meat, combined with progressive resistance training enhances lean tissue mass and muscle strength and reduces circulating IL-6 concentrations in elderly women: a cluster randomized controlled trial
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2014
      </year>
      <volume>
       99
      </volume>
      <fpage>
       899
      </fpage>
      <lpage>
       910
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXls1Oiur0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       24477043
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.113.064154
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR12">
     <label>
      12.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Marchesi
        </surname>
        <given-names>
         JR
        </given-names>
       </name>
       <name>
        <surname>
         Ravel
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The vocabulary of microbiome research: a proposal
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2015
      </year>
      <volume>
       3
      </volume>
      <pub-id pub-id-type="pmid">
       26229597
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4520061
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-015-0094-5
      </pub-id>
      <elocation-id>
       31
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR13">
     <label>
      13.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Biagi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians
      </article-title>
      <source>
       PLoS ONE
      </source>
      <year>
       2010
      </year>
      <volume>
       5
      </volume>
      <fpage>
       e10667
      </fpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2010PLoSO...510667B
      </pub-id>
      <pub-id pub-id-type="pmid">
       20498852
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2871786
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1371/journal.pone.0010667
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR14">
     <label>
      14.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grosicki
        </surname>
        <given-names>
         GJ
        </given-names>
       </name>
       <name>
        <surname>
         Fielding
        </surname>
        <given-names>
         RA
        </given-names>
       </name>
       <name>
        <surname>
         Lustgarten
        </surname>
        <given-names>
         MS
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota contribute to age-related changes in skeletal muscle size, composition, and function: biological basis for a gut-muscle axis
      </article-title>
      <source>
       Calcif. Tissue Int.
      </source>
      <year>
       2018
      </year>
      <volume>
       102
      </volume>
      <fpage>
       433
      </fpage>
      <lpage>
       442
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhslWjurrJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       29058056
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s00223-017-0345-5
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR15">
     <label>
      15.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Aging gut microbiota at the cross-road between nutrition, physical frailty, and sarcopenia: is there a gut-muscle axis?
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2017
      </year>
      <volume>
       9
      </volume>
      <fpage>
       1303
      </fpage>
      <pub-id pub-id-type="pmid">
       29189738
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5748753
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu9121303
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR16">
     <label>
      16.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ticinesi
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota composition is associated with polypharmacy in elderly hospitalized patients
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2017
      </year>
      <volume>
       7
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2017NatSR...711102T
      </pub-id>
      <pub-id pub-id-type="pmid">
       28894183
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5593887
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-017-10734-y
      </pub-id>
      <elocation-id>
       11102
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR17">
     <label>
      17.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ridaura
        </surname>
        <given-names>
         VK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota from twins discordant for obesity modulate metabolism in mice
      </article-title>
      <source>
       Science (1979)
      </source>
      <year>
       2013
      </year>
      <volume>
       341
      </volume>
      <fpage>
       1241214
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR18">
     <label>
      18.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Prokopidis
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Chambers
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Witard
        </surname>
        <given-names>
         OC
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Mechanisms linking the gut-muscle axis with muscle protein metabolism and anabolic resistance: implications for older adults at risk of sarcopenia
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       1910
      </fpage>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2021.770455
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR19">
     <label>
      19.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Raj
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Dileep
        </surname>
        <given-names>
         U
        </given-names>
       </name>
       <name>
        <surname>
         Vaz
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Fuller
        </surname>
        <given-names>
         MF
        </given-names>
       </name>
       <name>
        <surname>
         Kurpad
        </surname>
        <given-names>
         AV
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Intestinal microbial contribution to metabolic leucine input in adult men
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       138
      </volume>
      <fpage>
       2217
      </fpage>
      <lpage>
       2221
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXht1ymtr7J
      </pub-id>
      <pub-id pub-id-type="pmid">
       18936222
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/jn.108.093021
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR20">
     <label>
      20.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Zhang
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Cheng
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <name>
        <surname>
         Hu
        </surname>
        <given-names>
         YM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota as a promising therapeutic target for age-related sarcopenia
      </article-title>
      <source>
       Ageing Res. Rev.
      </source>
      <year>
       2022
      </year>
      <volume>
       81
      </volume>
      <fpage>
       101739
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xis1aisr%2FN
      </pub-id>
      <pub-id pub-id-type="pmid">
       36182084
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.arr.2022.101739
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR21">
     <label>
      21.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         de Marco Castro
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Murphy
        </surname>
        <given-names>
         CH
        </given-names>
       </name>
       <name>
        <surname>
         Roche
        </surname>
        <given-names>
         HM
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Targeting the gut microbiota to improve dietary protein efficacy to mitigate sarcopenia
      </article-title>
      <source>
       Front. Nutr.
      </source>
      <year>
       2021
      </year>
      <volume>
       8
      </volume>
      <fpage>
       656730
      </fpage>
      <pub-id pub-id-type="pmid">
       34235167
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8256992
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fnut.2021.656730
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR22">
     <label>
      22.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lahiri
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The gut microbiota influences skeletal muscle mass and function in mice
      </article-title>
      <source>
       Sci. Transl. Med.
      </source>
      <year>
       2019
      </year>
      <volume>
       11
      </volume>
      <fpage>
       eaan5662
      </fpage>
      <pub-id pub-id-type="pmid">
       31341063
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7501733
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1126/scitranslmed.aan5662
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR23">
     <label>
      23.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Manickam
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <name>
        <surname>
         Oh
        </surname>
        <given-names>
         HYP
        </given-names>
       </name>
       <name>
        <surname>
         Tan
        </surname>
        <given-names>
         CK
        </given-names>
       </name>
       <name>
        <surname>
         Paramalingam
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Wahli
        </surname>
        <given-names>
         W
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Metronidazole causes skeletal muscle atrophy and modulates muscle chronometabolism
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2018
      </year>
      <volume>
       19
      </volume>
      <fpage>
       2418
      </fpage>
      <pub-id pub-id-type="pmid">
       30115857
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6121908
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms19082418
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR24">
     <label>
      24.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus statement on the definition and scope of prebiotics
      </article-title>
      <source>
       Nat. Rev. Gastroenterol. Hepatol.
      </source>
      <year>
       2017
      </year>
      <volume>
       14
      </volume>
      <fpage>
       491
      </fpage>
      <lpage>
       502
      </lpage>
      <pub-id pub-id-type="pmid">
       28611480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/nrgastro.2017.75
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR25">
     <label>
      25.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Buigues
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effect of a prebiotic formulation on frailty syndrome: a randomized, double-blind clinical trial
      </article-title>
      <source>
       Int. J. Mol. Sci.
      </source>
      <year>
       2016
      </year>
      <volume>
       17
      </volume>
      <fpage>
       932
      </fpage>
      <pub-id pub-id-type="pmid">
       27314331
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4926465
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/ijms17060932
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR26">
     <label>
      26.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Theou
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Can a prebiotic formulation reduce frailty levels in older people?
      </article-title>
      <source>
       J. Frailty Aging
      </source>
      <year>
       2018
      </year>
      <volume>
       8
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       5
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR27">
     <label>
      27.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Desmedt
        </surname>
        <given-names>
         O
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Effects of prebiotics on affect and cognition in human intervention studies
      </article-title>
      <source>
       Nutr. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       77
      </volume>
      <fpage>
       81
      </fpage>
      <lpage>
       95
      </lpage>
      <pub-id pub-id-type="pmid">
       30535275
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nutrit/nuy052
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR28">
     <label>
      28.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cox
        </surname>
        <given-names>
         NJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The composition of the gut microbiome differs among community dwelling older people with good and poor appetite
      </article-title>
      <source>
       J. Cachexia Sarcopenia Muscle
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       368
      </fpage>
      <lpage>
       377
      </lpage>
      <pub-id pub-id-type="pmid">
       33580637
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8061352
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jcsm.12683
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR29">
     <label>
      29.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Guess
        </surname>
        <given-names>
         ND
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A randomized controlled trial: the effect of inulin on weight management and ectopic fat in subjects with prediabetes
      </article-title>
      <source>
       Nutr. Metab. (Lond.)
      </source>
      <year>
       2015
      </year>
      <volume>
       12
      </volume>
      <fpage>
       36
      </fpage>
      <pub-id pub-id-type="pmid">
       26500686
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12986-015-0033-2
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR30">
     <label>
      30.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Liber
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Szajewska
        </surname>
        <given-names>
         H
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of inulin-type fructans on appetite, energy intake, and body weight in children and adults: systematic review of randomized controlled trials
      </article-title>
      <source>
       Ann. Nutr. Metab.
      </source>
      <year>
       2013
      </year>
      <volume>
       63
      </volume>
      <fpage>
       42
      </fpage>
      <lpage>
       54
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXhsF2rsL7L
      </pub-id>
      <pub-id pub-id-type="pmid">
       23887189
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1159/000350312
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR31">
     <label>
      31.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Baker
        </surname>
        <given-names>
         JE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Visual paired associate learning deficits associated with elevated beta-amyloid in cognitively normal older adults
      </article-title>
      <source>
       Neuropsychology
      </source>
      <year>
       2019
      </year>
      <volume>
       33
      </volume>
      <fpage>
       964
      </fpage>
      <lpage>
       974
      </lpage>
      <pub-id pub-id-type="pmid">
       31368758
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1037/neu0000561
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR32">
     <label>
      32.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Hicks
        </surname>
        <given-names>
         EB
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Associations of visual paired associative learning task with global cognition and its potential usefulness as a screening tool for Alzheimer’s Dementia
      </article-title>
      <source>
       Int. Psychogeriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       33
      </volume>
      <fpage>
       1135
      </fpage>
      <lpage>
       1144
      </lpage>
      <pub-id pub-id-type="pmid">
       33336635
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S1041610220003841
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR33">
     <label>
      33.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Vulevic
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Drakoularakou
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Yaqoob
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Tzortzis
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Gibson
        </surname>
        <given-names>
         GR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2008
      </year>
      <volume>
       88
      </volume>
      <fpage>
       1438
      </fpage>
      <lpage>
       1484
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1cXhtlOqu7vP
      </pub-id>
      <pub-id pub-id-type="pmid">
       18996881
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3945/ajcn.2008.26242
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR34">
     <label>
      34.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Bergquist
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Performance-based clinical tests of balance and muscle strength used in young seniors: a systematic literature review
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2019
      </year>
      <volume>
       19
      </volume>
      <fpage>
       9
      </fpage>
      <pub-id pub-id-type="pmid">
       30626340
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6327480
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-018-1011-0
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR35">
     <label>
      35.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Harvey
        </surname>
        <given-names>
         NC
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Measures of physical performance and muscle strength as predictors of fracture risk independent of FRAX, Falls, and aBMD: a meta-analysis of the osteoporotic fractures in men (MrOS) study
      </article-title>
      <source>
       J. Bone Miner. Res.
      </source>
      <year>
       2018
      </year>
      <volume>
       33
      </volume>
      <fpage>
       2150
      </fpage>
      <lpage>
       2157
      </lpage>
      <pub-id pub-id-type="pmid">
       30011086
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1002/jbmr.3556
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR36">
     <label>
      36.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Walker
        </surname>
        <given-names>
         SN
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Maintenance of activity and eating change after a clinical trial of tailored newsletters with older rural women
      </article-title>
      <source>
       Nurs. Res.
      </source>
      <year>
       2010
      </year>
      <volume>
       59
      </volume>
      <fpage>
       311
      </fpage>
      <lpage>
       321
      </lpage>
      <pub-id pub-id-type="pmid">
       20697307
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2963620
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1097/NNR.0b013e3181ed6695
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR37">
     <label>
      37.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cesari
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Added value of physical performance measures in predicting adverse health-related events: results from the health, aging, and body composition study
      </article-title>
      <source>
       J. Am. Geriatr. Soc.
      </source>
      <year>
       2009
      </year>
      <volume>
       57
      </volume>
      <fpage>
       251
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19207142
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2695653
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1532-5415.2008.02126.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR38">
     <label>
      38.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tandon
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
      </article-title>
      <source>
       Sci. Rep.
      </source>
      <year>
       2019
      </year>
      <volume>
       9
      </volume>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2019NatSR...9.5473T
      </pub-id>
      <pub-id pub-id-type="pmid">
       30940833
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6445088
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41598-019-41837-3
      </pub-id>
      <elocation-id>
       5473
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR39">
     <label>
      39.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         So
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       107
      </volume>
      <fpage>
       965
      </fpage>
      <lpage>
       983
      </lpage>
      <pub-id pub-id-type="pmid">
       29757343
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy041
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR40">
     <label>
      40.
     </label>
     <mixed-citation publication-type="other">
      Cognitive Tests | Cambridge Cognition.
      <ext-link ext-link-type="uri" xlink:href="https://www.cambridgecognition.com/cantab/cognitive-tests/">
       https://www.cambridgecognition.com/cantab/cognitive-tests/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR41">
     <label>
      41.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The microbiota-gut-brain axis
      </article-title>
      <source>
       Physiol. Rev.
      </source>
      <year>
       2019
      </year>
      <volume>
       99
      </volume>
      <fpage>
       1877
      </fpage>
      <lpage>
       2013
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitFWjsLs%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       31460832
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1152/physrev.00018.2018
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR42">
     <label>
      42.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jenkins
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Nguyen
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <name>
        <surname>
         Polglaze
        </surname>
        <given-names>
         K
        </given-names>
       </name>
       <name>
        <surname>
         Bertrand
        </surname>
        <given-names>
         P
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2016
      </year>
      <volume>
       8
      </volume>
      <fpage>
       56
      </fpage>
      <pub-id pub-id-type="pmid">
       26805875
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4728667
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu8010056
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR43">
     <label>
      43.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Grenham
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <name>
        <surname>
         Clarke
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <name>
        <surname>
         Cryan
        </surname>
        <given-names>
         JF
        </given-names>
       </name>
       <name>
        <surname>
         Dinan
        </surname>
        <given-names>
         TG
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Brain-gut-microbe communication in health and disease
      </article-title>
      <source>
       Front. Physiol.
      </source>
      <year>
       2011
      </year>
      <volume>
       2
      </volume>
      <fpage>
       94
      </fpage>
      <pub-id pub-id-type="pmid">
       22162969
      </pub-id>
      <pub-id pub-id-type="pmcid">
       3232439
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3389/fphys.2011.00094
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR44">
     <label>
      44.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gaman
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Kuo
        </surname>
        <given-names>
         B
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Neuromodulatory processes of the brain–gut axis
      </article-title>
      <source>
       Neuromodulation
      </source>
      <year>
       2008
      </year>
      <volume>
       11
      </volume>
      <fpage>
       249
      </fpage>
      <lpage>
       259
      </lpage>
      <pub-id pub-id-type="pmid">
       19844605
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2763396
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/j.1525-1403.2008.00172.x
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR45">
     <label>
      45.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tran
        </surname>
        <given-names>
         TTT
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Prebiotic supplementation in frail older people affects specific gut microbiota taxa but not global diversity
      </article-title>
      <source>
       Microbiome
      </source>
      <year>
       2019
      </year>
      <volume>
       7
      </volume>
      <pub-id pub-id-type="pmid">
       30867067
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6417215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s40168-019-0654-1
      </pub-id>
      <elocation-id>
       39
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR46">
     <label>
      46.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Lancaster
        </surname>
        <given-names>
         SM
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Global, distinctive, and personal changes in molecular and microbial profiles by specific fibers in humans
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2022
      </year>
      <volume>
       30
      </volume>
      <fpage>
       848
      </fpage>
      <lpage>
       862.e7
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XhtFejtbvE
      </pub-id>
      <pub-id pub-id-type="pmid">
       35483363
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9187607
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2022.03.036
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR47">
     <label>
      47.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Healey
        </surname>
        <given-names>
         G
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study
      </article-title>
      <source>
       Br. J. Nutr.
      </source>
      <year>
       2018
      </year>
      <volume>
       119
      </volume>
      <fpage>
       176
      </fpage>
      <lpage>
       189
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhsVarsrg%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       29307330
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1017/S0007114517003440
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR48">
     <label>
      48.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Le Bastard
        </surname>
        <given-names>
         Q
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The effects of inulin on gut microbial composition: a systematic review of evidence from human studies
      </article-title>
      <source>
       Eur. J. Clin. Microbiol. Infect. Dis.
      </source>
      <year>
       2020
      </year>
      <volume>
       39
      </volume>
      <fpage>
       403
      </fpage>
      <lpage>
       413
      </lpage>
      <pub-id pub-id-type="pmid">
       31707507
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10096-019-03721-w
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR49">
     <label>
      49.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Watson
        </surname>
        <given-names>
         D
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Selective carbohydrate utilization by lactobacilli and bifidobacteria
      </article-title>
      <source>
       J. Appl. Microbiol.
      </source>
      <year>
       2013
      </year>
      <volume>
       114
      </volume>
      <fpage>
       1132
      </fpage>
      <lpage>
       1146
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC3sXkt1Kiu7o%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       23240984
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/jam.12105
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR50">
     <label>
      50.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wilson
        </surname>
        <given-names>
         B
        </given-names>
       </name>
       <name>
        <surname>
         Rossi
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Dimidi
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <name>
        <surname>
         Whelan
        </surname>
        <given-names>
         K
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials
      </article-title>
      <source>
       Am. J. Clin. Nutr.
      </source>
      <year>
       2019
      </year>
      <volume>
       109
      </volume>
      <fpage>
       1098
      </fpage>
      <lpage>
       1111
      </lpage>
      <pub-id pub-id-type="pmid">
       30949662
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ajcn/nqy376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR51">
     <label>
      51.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cherbut
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Michel
        </surname>
        <given-names>
         C
        </given-names>
       </name>
       <name>
        <surname>
         Lecannu
        </surname>
        <given-names>
         G
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats
      </article-title>
      <source>
       J. Nutr.
      </source>
      <year>
       2003
      </year>
      <volume>
       133
      </volume>
      <fpage>
       21
      </fpage>
      <lpage>
       27
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3sXjslejtg%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       12514261
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/jn/133.1.21
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR52">
     <label>
      52.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Genetic determinants of the gut microbiome in UK twins
      </article-title>
      <source>
       Cell Host Microbe
      </source>
      <year>
       2016
      </year>
      <volume>
       19
      </volume>
      <fpage>
       731
      </fpage>
      <lpage>
       743
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XntlShtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27173935
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4915943
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.chom.2016.04.017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR53">
     <label>
      53.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodrich
        </surname>
        <given-names>
         JK
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Human genetics shape the gut microbiome
      </article-title>
      <source>
       Cell
      </source>
      <year>
       2014
      </year>
      <volume>
       159
      </volume>
      <fpage>
       789
      </fpage>
      <lpage>
       799
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2cXhvV2msrnJ
      </pub-id>
      <pub-id pub-id-type="pmid">
       25417156
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4255478
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cell.2014.09.053
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR54">
     <label>
      54.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Yang
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Unfavourable intrauterine environment contributes to abnormal gut microbiome and metabolome in twins
      </article-title>
      <source>
       Gut
      </source>
      <year>
       2022
      </year>
      <volume>
       71
      </volume>
      <fpage>
       2451
      </fpage>
      <lpage>
       2462
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XivFegtb3P
      </pub-id>
      <pub-id pub-id-type="pmid">
       35387876
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1136/gutjnl-2021-326482
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR55">
     <label>
      55.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Xie
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Shotgun metagenomics of 250 adult twins reveals genetic and environmental impacts on the gut microbiome
      </article-title>
      <source>
       Cell Syst.
      </source>
      <year>
       2016
      </year>
      <volume>
       3
      </volume>
      <fpage>
       572
      </fpage>
      <lpage>
       584.e3
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC2sXhtFalsLw%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       27818083
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6309625
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.cels.2016.10.004
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR56">
     <label>
      56.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Stincone
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The return of metabolism: biochemistry and physiology of the pentose phosphate pathway
      </article-title>
      <source>
       Biol. Rev.
      </source>
      <year>
       2015
      </year>
      <volume>
       90
      </volume>
      <fpage>
       927
      </fpage>
      <lpage>
       963
      </lpage>
      <pub-id pub-id-type="pmid">
       25243985
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1111/brv.12140
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR57">
     <label>
      57.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Wagner
        </surname>
        <given-names>
         KR
        </given-names>
       </name>
       <name>
        <surname>
         Kauffman
        </surname>
        <given-names>
         FC
        </given-names>
       </name>
       <name>
        <surname>
         Max
        </surname>
        <given-names>
         SR
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The pentose phosphate pathway in regenerating skeletal muscle
      </article-title>
      <source>
       Biochem. J.
      </source>
      <year>
       1978
      </year>
      <volume>
       170
      </volume>
      <fpage>
       17
      </fpage>
      <lpage>
       22
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DyaE1cXhsV2ks7Y%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       629775
      </pub-id>
      <pub-id pub-id-type="pmcid">
       1183856
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1042/bj1700017
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR58">
     <label>
      58.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Valentino
        </surname>
        <given-names>
         T
        </given-names>
       </name>
       <name>
        <surname>
         Figueiredo
        </surname>
        <given-names>
         VC
        </given-names>
       </name>
       <name>
        <surname>
         Mobley
        </surname>
        <given-names>
         CB
        </given-names>
       </name>
       <name>
        <surname>
         McCarthy
        </surname>
        <given-names>
         JJ
        </given-names>
       </name>
       <name>
        <surname>
         Vechetti
        </surname>
        <given-names>
         IJ
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Evidence of myomiR regulation of the pentose phosphate pathway during mechanical load‐induced hypertrophy
      </article-title>
      <source>
       Physiol. Rep.
      </source>
      <year>
       2021
      </year>
      <volume>
       9
      </volume>
      <fpage>
       15137
      </fpage>
      <pub-id pub-id-type="doi">
       10.14814/phy2.15137
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR59">
     <label>
      59.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carabotti
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Scirocco
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Maselli
        </surname>
        <given-names>
         MA
        </given-names>
       </name>
       <name>
        <surname>
         Severi
        </surname>
        <given-names>
         C
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems
      </article-title>
      <source>
       Ann. Gastroenterol.
      </source>
      <year>
       2015
      </year>
      <volume>
       28
      </volume>
      <fpage>
       203
      </fpage>
      <pub-id pub-id-type="pmid">
       25830558
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4367209
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR60">
     <label>
      60.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Connell
        </surname>
        <given-names>
         E
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
      </article-title>
      <source>
       Mol. Neurodegener.
      </source>
      <year>
       2022
      </year>
      <volume>
       17
      </volume>
      <fpage>
       43
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XitVeqt7bF
      </pub-id>
      <pub-id pub-id-type="pmid">
       35715821
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9204954
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13024-022-00548-6
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR61">
     <label>
      61.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Jeong
        </surname>
        <given-names>
         S
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Cognitive function associated with gut microbial abundance in sucrose and S-adenosyl-L-methionine (SAMe) metabolic pathways
      </article-title>
      <source>
       J. Alzheimer’s Dis.
      </source>
      <year>
       2022
      </year>
      <volume>
       87
      </volume>
      <fpage>
       1115
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38Xhtl2lurvK
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3233/JAD-215090
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR62">
     <label>
      62.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         Z
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Altered actinobacteria and firmicutes phylum associated epitopes in patients with Parkinson’s disease
      </article-title>
      <source>
       Front. Immunol.
      </source>
      <year>
       2021
      </year>
      <volume>
       12
      </volume>
      <fpage>
       2541
      </fpage>
     </mixed-citation>
    </ref>
    <ref id="CR63">
     <label>
      63.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Fernandez-Real
        </surname>
        <given-names>
         J-M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Gut microbiota interacts with brain microstructure and function
      </article-title>
      <source>
       J. Clin. Endocrinol. Metab.
      </source>
      <year>
       2015
      </year>
      <volume>
       100
      </volume>
      <fpage>
       4505
      </fpage>
      <lpage>
       4513
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC28XjtlSntr0%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       26445114
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1210/jc.2015-3076
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR64">
     <label>
      64.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Tooley
        </surname>
        <given-names>
         KL
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Effects of the human gut microbiota on cognitive performance, brain structure and function: a narrative review
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2020
      </year>
      <volume>
       12
      </volume>
      <fpage>
       3009
      </fpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3cXitlyjur3K
      </pub-id>
      <pub-id pub-id-type="pmid">
       33007941
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7601389
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu12103009
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR65">
     <label>
      65.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Witham
        </surname>
        <given-names>
         MD
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2020
      </year>
      <volume>
       21
      </volume>
      <pub-id pub-id-type="pmid">
       32738919
      </pub-id>
      <pub-id pub-id-type="pmcid">
       7395975
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-020-04613-7
      </pub-id>
      <elocation-id>
       694
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR66">
     <label>
      66.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Goodwin
        </surname>
        <given-names>
         VA
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       INCLUDE older people: best practice recommendations in health and social care research
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2023
      </year>
      <volume>
       52
      </volume>
      <fpage>
       afad082
      </fpage>
      <pub-id pub-id-type="pmid">
       37261448
      </pub-id>
      <pub-id pub-id-type="pmcid">
       10234283
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afad082
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR67">
     <label>
      67.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Cruz-Jentoft
        </surname>
        <given-names>
         AJ
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Sarcopenia: revised European consensus on definition and diagnosis
      </article-title>
      <source>
       Age Ageing
      </source>
      <year>
       2019
      </year>
      <volume>
       48
      </volume>
      <fpage>
       601
      </fpage>
      <lpage>
       601
      </lpage>
      <pub-id pub-id-type="pmid">
       31081853
      </pub-id>
      <pub-id pub-id-type="pmcid">
       6593317
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/ageing/afz046
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR68">
     <label>
      68.
     </label>
     <mixed-citation publication-type="other">
      Verdi, S. et al. TwinsUK: The UK Adult Twin Registry Update.
      <italic>
       Twin Res. Hum. Genetics
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1017/thg.2019.65">
       https://doi.org/10.1017/thg.2019.65
      </ext-link>
      (2019).
     </mixed-citation>
    </ref>
    <ref id="CR69">
     <label>
      69.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Ni Lochlainn
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       The PROMOTe study: targeting the gut microbiome with prebiotics to overcome age-related anabolic resistance: protocol for a double-blinded, randomised, placebo-controlled trial
      </article-title>
      <source>
       BMC Geriatr.
      </source>
      <year>
       2021
      </year>
      <volume>
       21
      </volume>
      <fpage>
       407
      </fpage>
      <pub-id pub-id-type="pmid">
       34210274
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8248289
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s12877-021-02301-y
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR70">
     <label>
      70.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Masoli
        </surname>
        <given-names>
         JAH
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond
      </article-title>
      <source>
       Trials
      </source>
      <year>
       2021
      </year>
      <volume>
       22
      </volume>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB3MXislajt73K
      </pub-id>
      <pub-id pub-id-type="pmid">
       34895305
      </pub-id>
      <pub-id pub-id-type="pmcid">
       8665850
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1186/s13063-021-05880-8
      </pub-id>
      <elocation-id>
       911
      </elocation-id>
     </mixed-citation>
    </ref>
    <ref id="CR71">
     <label>
      71.
     </label>
     <mixed-citation publication-type="other">
      Office for National Statistics. Internet users UK 2020.
      <ext-link ext-link-type="uri" xlink:href="https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020">
       https://www.ons.gov.uk/businessindustryandtrade/itandinternetindustry/bulletins/internetusers/2020
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR72">
     <label>
      72.
     </label>
     <mixed-citation publication-type="other">
      Doody, P. et al.
      <italic>
       Internet access and use among adults aged 50 and over in Ireland: Results from Wave 5 of The Irish Longitudinal Study on Ageing
      </italic>
      .
      <italic>
       The Irish Longitudinal Study on Ageing
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.38018/TildaRe.2020-06">
       https://doi.org/10.38018/TildaRe.2020-06
      </ext-link>
      (2020).
     </mixed-citation>
    </ref>
    <ref id="CR73">
     <label>
      73.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Carter
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Development of a UK Online 24-h Dietary Assessment Tool: myfood24
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2015
      </year>
      <volume>
       7
      </volume>
      <fpage>
       4016
      </fpage>
      <lpage>
       4032
      </lpage>
      <pub-id pub-id-type="pmid">
       26024292
      </pub-id>
      <pub-id pub-id-type="pmcid">
       4488770
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu7064016
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR74">
     <label>
      74.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Threapleton
        </surname>
        <given-names>
         DE
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Usability of myfood24 healthcare and mathematical diet optimisation in clinical populations: a pilot feasibility randomised controlled trial
      </article-title>
      <source>
       Nutrients
      </source>
      <year>
       2022
      </year>
      <volume>
       14
      </volume>
      <fpage>
       1768
      </fpage>
      <pub-id pub-id-type="pmid">
       35565736
      </pub-id>
      <pub-id pub-id-type="pmcid">
       9101756
      </pub-id>
      <pub-id pub-id-type="doi">
       10.3390/nu14091768
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR75">
     <label>
      75.
     </label>
     <mixed-citation publication-type="other">
      Strength exercises—NHS.
      <ext-link ext-link-type="uri" xlink:href="https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/">
       https://www.nhs.uk/live-well/exercise/strength-and-flexibility-exercises/strength-exercises/
      </ext-link>
      .
     </mixed-citation>
    </ref>
    <ref id="CR76">
     <label>
      76.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Millor
        </surname>
        <given-names>
         N
        </given-names>
       </name>
       <name>
        <surname>
         Lecumberri
        </surname>
        <given-names>
         P
        </given-names>
       </name>
       <name>
        <surname>
         Gómez
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Martínez-Ramírez
        </surname>
        <given-names>
         A
        </given-names>
       </name>
       <name>
        <surname>
         Izquierdo
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       An evaluation of the 30-s chair stand test in older adults: frailty detection based on kinematic parameters from a single inertial unit
      </article-title>
      <source>
       J. Neuroeng. Rehabil.
      </source>
      <year>
       2013
      </year>
      <volume>
       10
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       9
      </lpage>
      <pub-id pub-id-type="doi">
       10.1186/1743-0003-10-86
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR77">
     <label>
      77.
     </label>
     <mixed-citation publication-type="other">
      Dodds, R. M. et al. Prevalence and factors associated with poor performance in the 5‐chair stand test: findings from the Cognitive Function and Ageing Study II and proposed Newcastle protocol for use in the assessment of sarcopenia.
      <italic>
       J. Cachexia Sarcopenia Muscle
      </italic>
      <ext-link ext-link-type="doi" xlink:href="10.1002/jcsm.12660">
       https://doi.org/10.1002/jcsm.12660
      </ext-link>
      (2021).
     </mixed-citation>
    </ref>
    <ref id="CR78">
     <label>
      78.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Li
        </surname>
        <given-names>
         H
        </given-names>
       </name>
       <name>
        <surname>
         Durbin
        </surname>
        <given-names>
         R
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Fast and accurate short read alignment with Burrows–Wheeler transform
      </article-title>
      <source>
       Bioinformatics
      </source>
      <year>
       2009
      </year>
      <volume>
       25
      </volume>
      <fpage>
       1754
      </fpage>
      <lpage>
       1760
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD1MXot1Cjtbo%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       19451168
      </pub-id>
      <pub-id pub-id-type="pmcid">
       2705234
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/bioinformatics/btp324
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR79">
     <label>
      79.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Huerta-Cepas
        </surname>
        <given-names>
         J
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Fast genome-wide functional annotation through orthology assignment by eggNOG-Mapper
      </article-title>
      <source>
       Mol. Biol. Evol.
      </source>
      <year>
       2017
      </year>
      <volume>
       34
      </volume>
      <fpage>
       2115
      </fpage>
      <lpage>
       2122
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BC1cXhvFaru7vF
      </pub-id>
      <pub-id pub-id-type="pmid">
       28460117
      </pub-id>
      <pub-id pub-id-type="pmcid">
       5850834
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/molbev/msx148
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR80">
     <label>
      80.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kanehisa
        </surname>
        <given-names>
         M
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       KEGG: Kyoto Encyclopedia of Genes and Genomes
      </article-title>
      <source>
       Nucleic Acids Res.
      </source>
      <year>
       2000
      </year>
      <volume>
       28
      </volume>
      <fpage>
       27
      </fpage>
      <lpage>
       30
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BD3cXhvVGqu74%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10592173
      </pub-id>
      <pub-id pub-id-type="pmcid">
       102409
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1093/nar/28.1.27
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR81">
     <label>
      81.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Kim
        </surname>
        <given-names>
         B-R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Deciphering diversity indices for a better understanding of microbial communities
      </article-title>
      <source>
       J. Microbiol Biotechnol.
      </source>
      <year>
       2017
      </year>
      <volume>
       27
      </volume>
      <fpage>
       2089
      </fpage>
      <lpage>
       2093
      </lpage>
      <pub-id pub-id-type="pmid">
       29032640
      </pub-id>
      <pub-id pub-id-type="doi">
       10.4014/jmb.1709.09027
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR82">
     <label>
      82.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Gacesa
        </surname>
        <given-names>
         R
        </given-names>
       </name>
       <etal/>
      </person-group>
      <article-title xml:lang="en">
       Environmental factors shaping the gut microbiome in a Dutch population
      </article-title>
      <source>
       Nature
      </source>
      <year>
       2022
      </year>
      <volume>
       604
      </volume>
      <fpage>
       732
      </fpage>
      <lpage>
       739
      </lpage>
      <pub-id assigning-authority="NASA Astrophysics Data System" pub-id-type="other">
       2022Natur.604..732G
      </pub-id>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:CAS:528:DC%2BB38XpvV2iu7k%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       35418674
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/s41586-022-04567-7
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR83">
     <label>
      83.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Sahu
        </surname>
        <given-names>
         M
        </given-names>
       </name>
       <name>
        <surname>
         Prasuna
        </surname>
        <given-names>
         J
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Twin studies: a unique epidemiological tool
      </article-title>
      <source>
       Indian J. Commun. Med.
      </source>
      <year>
       2016
      </year>
      <volume>
       41
      </volume>
      <fpage>
       177
      </fpage>
      <pub-id pub-id-type="doi">
       10.4103/0970-0218.183593
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR84">
     <label>
      84.
     </label>
     <mixed-citation publication-type="other">
      StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC. (2019).
     </mixed-citation>
    </ref>
    <ref id="CR85">
     <label>
      85.
     </label>
     <mixed-citation publication-type="other">
      RStudio Team &amp; RStudio: Integrated Development for R.
      <italic>
       RStudio
      </italic>
      . (RStudio, Inc., Boston, MA, 2015).
     </mixed-citation>
    </ref>
    <ref id="CR86">
     <label>
      86.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The sensitivity and specificity of the Goldberg cut-off for EI:BMR for identifying diet reports of poor validity
      </article-title>
      <source>
       Eur. J. Clin. Nutr.
      </source>
      <year>
       2000
      </year>
      <volume>
       54
      </volume>
      <fpage>
       395
      </fpage>
      <lpage>
       404
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3c3osVWjuw%3D%3D
      </pub-id>
      <pub-id pub-id-type="pmid">
       10822286
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ejcn.1600971
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR87">
     <label>
      87.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Black
        </surname>
        <given-names>
         AE
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Critical evaluation of energy intake using the Goldberg cut-off for energy intake:basal metabolic rate. A practical guide to its calculation, use and limitations
      </article-title>
      <source>
       Int. J. Obes.
      </source>
      <year>
       2000
      </year>
      <volume>
       24
      </volume>
      <fpage>
       1119
      </fpage>
      <lpage>
       1130
      </lpage>
      <pub-id assigning-authority="ChemPort ( Chemical Abstract Service )" pub-id-type="other">
       1:STN:280:DC%2BD3cvosFehsg%3D%3D
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1038/sj.ijo.0801376
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR88">
     <label>
      88.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <collab>
        Dietary reference values for food energy and nutrients for the United Kingdom.
       </collab>
      </person-group>
      <article-title xml:lang="en">
       Report of the panel on dietary reference values of the committee on medical aspects of food policy
      </article-title>
      <source>
       Rep. Health Soc. Subj. (Lond.)
      </source>
      <year>
       1991
      </year>
      <volume>
       41
      </volume>
      <fpage>
       1
      </fpage>
      <lpage>
       210
      </lpage>
     </mixed-citation>
    </ref>
    <ref id="CR89">
     <label>
      89.
     </label>
     <mixed-citation publication-type="other">
      Oksanen, J. et al. vegan: Community Ecology Package [R package version 2.6-4].
      <ext-link ext-link-type="uri" xlink:href="https://cran.r-project.org/package=vegan">
       https://cran.r-project.org/package=vegan
      </ext-link>
      (2022).
     </mixed-citation>
    </ref>
    <ref id="CR90">
     <label>
      90.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       The liability threshold model for censored twin data
      </article-title>
      <source>
       Comput. Stat. Data Anal.
      </source>
      <year>
       2016
      </year>
      <volume>
       93
      </volume>
      <fpage>
       324
      </fpage>
      <lpage>
       335
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3406215
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1016/j.csda.2015.01.014
      </pub-id>
     </mixed-citation>
    </ref>
    <ref id="CR91">
     <label>
      91.
     </label>
     <mixed-citation publication-type="journal">
      <person-group person-group-type="author">
       <name>
        <surname>
         Scheike
        </surname>
        <given-names>
         TH
        </given-names>
       </name>
       <name>
        <surname>
         Holst
        </surname>
        <given-names>
         KK
        </given-names>
       </name>
       <name>
        <surname>
         Hjelmborg
        </surname>
        <given-names>
         JB
        </given-names>
       </name>
      </person-group>
      <article-title xml:lang="en">
       Estimating heritability for cause specific mortality based on twin studies
      </article-title>
      <source>
       Lifetime Data Anal.
      </source>
      <year>
       2014
      </year>
      <volume>
       20
      </volume>
      <fpage>
       210
      </fpage>
      <lpage>
       233
      </lpage>
      <pub-id assigning-authority="American Mathematical Society" pub-id-type="other">
       3181012
      </pub-id>
      <pub-id pub-id-type="pmid">
       23378036
      </pub-id>
      <pub-id pub-id-type="doi">
       10.1007/s10985-013-9244-x
      </pub-id>
     </mixed-citation>
    </ref>
   </ref-list>
  </ref-list>
  <app-group>
   <app id="App1" specific-use="web-only">
    <sec id="Sec25">
     <title>
      补充信息
     </title>
     <p id="Par73">
      <supplementary-material content-type="local-data" id="MOESM1" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM1_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Supplementary Information
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM2" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM2_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Peer Review File
         </p>
        </caption>
       </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="MOESM3" xlink:title="Supplementary information">
       <media mime-subtype="pdf" mimetype="application" xlink:href="MediaObjects/41467_2024_46116_MOESM3_ESM.pdf">
        <caption xml:lang="en">
         <p>
          Reporting Summary
         </p>
        </caption>
       </media>
      </supplementary-material>
     </p>
    </sec>
   </app>
  </app-group>
  <notes notes-type="ESMHint">
   <title>
    补充信息
   </title>
   <p>
    The online version contains supplementary material available at
    <ext-link ext-link-type="doi" xlink:href="10.1038/s41467-024-46116-y">
     https://doi.org/10.1038/s41467-024-46116-y
    </ext-link>
    .
   </p>
  </notes>
  <notes notes-type="Misc">
   <p>
    <bold>
     Publisher’s note
    </bold>
    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
   </p>
  </notes>
 </back>
</article>
